Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Staphylococcus aureus subsp. aureus USA300, USA300; FPR3757

>SAUSA300_1007 inositol monophosphatase family protein
MALYGFAQGLIQEAGIRIKQLMEQNLTIETKSNPNDLVTNVDKATEDFIF
DTILETYPNHQVLGEEGHGHDIDTSKGTVWIVDPIDGTLNFVHQQENFAI
SIGIYIDGKPYAGFVYDVMADVLYHAKVGEGAYRGSQPLKPLNDSNLRQS
IIGINPNWLTKPILGEIFKEIVNDSRSARAYGSAALEIVSVATGNLEAYM
TPRLQPWDFAGGLVILYEVNGQASNLLGEPLTISGPNSILVGNRGLHQEI
SNDYLEPHHDALIQLHEQRFKRKSK
>SAUSA300_0583 conserved hypothetical protein
MLCESKIINKNPKYRIIKYNDEYLMIDIISTWISLFFPFINWFIPKRYVK
ISREEFENLNIVKPAKKNVFWPVAGISTLFAVTLRKYTHLLDTQLDRKLV
IAICCITFIGILTFYVRLIKKSSLNIYNTKNKRSKIILIPTLKNFCLTLF
RYAFFILWTVIFSYALLSMSYQNIIVYFAWITAIMGFFLVNIALIIDKNI
HVILKN
>SAUSA300_2471 perfringolysin O regulator protein
MDILLGVGTLVLVLVIMTLFLKYAPYGKQGLQALSGAACATFLPQAFLSY
AIGGVFDIKFLQDIGDLAGSLSGIAVGILTCLNLGVAPVFAVIVGLVLHD
FKLLPAFIAAYGVAFLIKWIEKKVPEGLDLIVVILFAPAIAFGLASIITP
GVLATLKQIGSAVTAVGDNNPYALAVILGLVIPVTGMTPLSSMVLTSLLG
LTGVPMAIGALTCTGSSFVNLILFRKLNIGGPSKAFAVCIEPLTQIDLIA
QYPVQLYGTNALIGVVNACIVTFSGLVIGVKGMATPIAGAIVLFGFNNAV
TSIVTIATVIIVSIVLAYIIGTLINKFNLMNINFKMPSKKNHIKESV
>SAUSA300_1277 conserved hypothetical protein
MTLFDMPNYLWITTLIMILLTIFCCLVLNKWFVSAVITFVILGVLAFFIP
NFQDIKYQPLLGYAAFLAIMSLLISFLLWYFTRNWRKERKARKLEKQIEK
YGYEGAELRRKDKK
>SAUSA300_0091 putative permease
MTDLLKIKNFRLFFLAEIISAFGVGISTVGANWYLIDKTNDSQLLGIMLA
LNVLSGFLASPIIGGLADKYNRRNIILITYLLQVILYLLIVIALVMIGFE
TYLVIGFAIVNGIGWTTYMATSRSLVKQILKPDQYTDANSLLEISLQTGM
FIAGGLSGILYKINGFTLIIAMTIMMFLISIFMLFRLHVDKPTHSEEEST
NSLLQEYLLGWKFLKDNMMIFIFGVISIIPMVFTMIFNISLPGYVYNVLK
LSSVQFGFSDMLYGIGGLCAGLISAILSKKISTKVLIFLLYFILVINSAL
FIWINSAFYLFIGSFILGYSISSIRIYMNTAIMNTVSDKYVGRSFTIWTS
ISLLLQSLIAPFLGRWINEINDKFGFYIILILSLLIFVTLLLVNKTGKIK
YAHKEE
>SAUSA300_0908 NAD(+)/NADH kinase
MRYTILTKGDSKSNALKHKMMNYMKDFRMIEDSENPEIVISVGGDGTLLQ
AFHQYSHMLSKVAFVGVHTGHLGFYADWLPHEVEKLIIEINNSEFQVIEY
PLLEIIMRYNDNGYETRYLALNEATMKTENGSTLVVDVNLRGKHFERFRG
DGLCVSTPSGSTAYNKALGGALIHPSLEAMQITEIASINNRVFRTVGSPL
VLPKHHTCLISPVNHDTIRMTIDHVSIKHKNVNSIQYRVANEKVRFARFR
PFPFWKRVHDSFISSDEER
>SAUSA300_0241 PTS system, sorbitol-specific IIC component
MSYFTDFVRGFLDLGATVILPVVIFLLGLFFRQKIGAAFRSGLTIGVAFV
GIFLVIDLLVKNLGPAAQAMVKNLGVSLNVIDVGWPATSSIAWASSVAAF
IIPLGIIVNVVLLVTKVTKTMNVDIWNFWHYTFTAAMVYAVSGSIWQALL
AAVIFQIICLKVADWTAPMMSEFFDLPGVSIATGSTISYAPGIYLVKLLQ
KVPGLNKLDADPETIQKRFGAFGESIFVGLILGLGIGVLAGYKPGDIINL
GMSMAAVMVLMPRMVKILMEGLMPVSESARTWLNKRFGEREIYIGLDAAV
ALGHPAVISTALILVPITVLLAVILPGNQVLPFGDLATIPFVVAFIVGAA
RGNIIHSVIVGTIMIAISLYIATDVAPIFTDMAKGTNVQMPKGSSEISSI
DQGGNIVNYLIFKLFSLFN
>SAUSA300_1328 putative drug transporter
MEKPSREAFEGNNKLLIGIVLSVITFWLFAQSLVNVVPILEDSFNTDIGT
VNIAVSITALFSGMFVVGAGGLADKYGRIKLTNIGIILNILGSLLIIISN
IPLLLIIGRLIQGLSAACIMPATLSIIKSYYIGKDRQRALSYWSIGSWGG
SGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSISLNK
FDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITLLAIAIGSFSLFIVL
EKRATNPLIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYS
SLQAGSLSITYLVMVLIMIRVGEKLLQTLGCKKPMLIGTGVLIVGECLIS
LTFLPEIFYVICCIIGYLFFGLGLGIYATPSTDTAIANAPLEKVGVAAGI
YKMASALGGAFGVALSGAVYAIVSNMTNIYTGAMIALWLNAGMGILSFVI
ILLLVPKQNDTQL
>SAUSA300_0211 maltose ABC transporter, permease protein
MTKKKNILKAIGIYSFIAMMFVIILYPLLWTFGISLNPGTNLYGAKMIPD
NATFKNYAFLLFDDSSQYLTWYKNTLIVASANALFSVIFVTLTAYAFSRY
RFVGRKYGLITFLILQMFPVLMAMVAIYILLNTIGLLDSLFGLTLVYIGG
SIPMNAFLVKGYFDTIPKELDESAKIDGAGHMRIFLQIMLPLAKPILAVV
ALFNFMGPFMDFILPKILLRSPEKFTLAVGLFNFINDKYANNFTVFAAGA
IMIAVPIAIVFLFLQRYLVSGLTTGATKG
>SAUSA300_2576 phosphotransferase system, fructose-specific IIABC component
MKIVAITSCPNGIAHTYMAQEKLEQVAKEMGVDIKVETQGGVGAENVLTT
QDIEEADGVIIAADKQVDLSRFVGKRLINENVREGIHNPRGLIQRIINQD
APIYQSETNYHSKDRGKSKSGIQMVYQHLMNGVSFMVPFIVVGGLLIAIA
LTLGGETTSKGLVIPDDSFWKSIENIGSLAFKFMVPILAGYIAVSIADKP
GLVPGMIGGAIAADGSFYGSDAGAGFLGGIVAGFLAGYIAKWIKDIKVPK
AMAPIMPIIIIPIISSVVVGLIFIFLIGAPISNIFEALTTWLKSMQGANI
IILAMIIGAMIAFDMGGPVNKVAFLFGSALIAEGNYAVMGMVAVAVCTPP
IGLGLATFVQKYKFNHSEREMGKASFTMGLFGITEGAIPFAAQDPLRIIP
ANIIGAMIASVIAAIGGVGDRVAHGGPIVAVLGGIDHVLWFIFAVIVGSL
VTMTTVLLLKRNTPVIAVDAPAQHTQLHDTDITQHDTEVDNVDNTAKHSH
LNKPSHVFDQQTMIITDHDMSRNEAIDMLIHKLKICRYVEHTSHLKNAIL
EREMGSTTAIGMNVAIPHAKSDVVKQPIVAVMKNNHGVKWDSLDGSLPQL
IFLIAVPNNSQDTHLKILQRLSKALMNDETRQSLINANSTTEIYNLLMKI
>SAUSA300_0783 phosphoglycerate mutase family protein
MRHGQTLFNFKGLIQGFGDSPLTELGIAQAQKARSYYETKGINFDLYASS
TQERASDTLENVAPNQSYQRFKGLKEWHFGIFEGESVYLFDNLYKPEDLF
GDRIVPFKGEARQQVEERIVKTLHDIMSQTKNNALVVSHGTIMGVFLRYC
LKLDEALKHNIGNCNILKFEYDNGTFKFVELIDPNL
>SAUSA300_0558 putative proline/betaine transporter
MDFNKENINMVDAKKAKKTVVATGIGNAMEWFDFGVYAYTTAYIGANFFS
PVENADIRQMLTFAALAIAFLLRPIGGVVFGIIGDKYGRKVVLTSTIILM
AFSTLTIGLLPSYDQIGLWAPILLLLARVLQGFSTGGEYAGAMTYVAESS
PDKRRNSLGSGLEIGTLSGYIAASIMIAVLTFFLTDEQMASFGWRIPFLL
GLFLGLFGLYLRRKLEESPVFENDVATQPERDNINFLQIIRFYYKDIFVC
FVAVVFFNVTNYMVTAYLPTYLEQVIKLDATTTSVLITCVMAIMIPLALM
FGKLADKIGEKKVFLIGTGGLTLFSIIAFMLLHSQSFVVIVIGIFILGFF
LSTYEATMPGSLPTMFYSHIRYRTLSVTFNISVSIFGGTTPLVATWLVTK
TGDPLAPAYYLTAISVIGFLVITFLHLSTAGKSLKGSYPNVDNEQDRAYY
AEHPKEALWWVKERKN
>SAUSA300_0210 maltose ABC transporter, permease protein
MTKRNPKLAALLSVIPGLGQFYNKRPIKGTIFFIFFISFISVFYSFLNIG
FWGLFTLGTVPKLDDSRVLLAQGIISILLVAFAIMLYIINILDAYRNAER
FNRNEEIKDPKARMVATWDKTFPYLLISPGTFLLIFVVVFPLIFMFGVAF
TNYNLYNAPPRHTLEWVGLDNFKTLFTIGVWRKTFFSVITWTLVWTLVAT
TLQIALGLFLAIIVNHPVVKGKKFIRTVLILPWAVPSFVTILIFVALFND
EFGAINNDILQPLLGVAPAWLSDPFWAKVALIGIQVWLGFPFVFALFTGV
LQSISSDWYEAADMDGASSWQKFRNITFPHVIYATAPLLIMQYAGNFNNF
NLIYLFNKGGPPVSGQNAGSTDILISWVYNLTFEFNNFNMGAVVSLIIGF
IVAIVAFIQFRRTSTFKDEGGL
>SAUSA300_0106 putative drug transporter
MNETYRGGNKLILGIVLGVITFWLFAQSLVNVVPNLQQSFGTDMGTISIA
VSLTALFSGMFVVGAGGLADKIGRVKMTNIGLLLSIIGSALIIITNLPAL
LILGRVIQGVSAACIMPSTLAIMKTYYQGAERQRALSYWSIGSWGGSGIC
SLFGGAVATTMGWRWIFIFSIIVAVLSMLLIKGTPETKSEITNTHKFDVA
GLIVLVVMLLSLNVVITKGAALGYTSLWFFGLIAIVIVAFFIFLNVEKKV
DNPLIDFKLFENKPYTGATISNFLLNGVAGTLIVANTFVQQGLGYTALQA
GYLSITYLIMVLLMIRVGEKLLQKMGSKRPMLLGTFIVVIGIALISLVFL
PGIFYVISCVVGYLCFGLGLGIYATPSTDTAISNAPLDKVGVASGIYKMA
SSLGGAFGVAISGAVYAGAVAATSIHTGAMIALWVNVLMGIMAFIAILFA
IPNDDKRVKDAK
>SAUSA300_1902 conserved hypothetical protein
MTNGYIGSYTKKNGKGIYRFELNENQSRIDLLETGFELEASTYLVRNNEV
LYGINKEGEQCGVASLKIDDNGELHLLNKCLSSKAGTGCYVSISEDKRYL
FEAVYGAGIIRMYELNTHTGEIIRLIQELAHDFPTGTHERQDHPHAHYIN
QTPDGKYVAVTDLGADRIVTYKFDDNGFEFYKESLFKDSDGTRHIEFHDN
GKFAYVVHELSNTVSVAEYNDGKFEELERHLTIPENFDGDTKLAAVRLSH
DQQFLYVSNRGHDSIAIFKVLDNGQHLELVTITESGGQFPRDFNIASSDD
LLVCAHEQGDSVVTVFERNKETGKITLCDNTRVASEGVCVIF
>SAUSA300_0130 NAD-dependent epimerase/dehydratase family protein
MEDLERVLITGGAGFIGSHLVDDLQQDYDVYVLDNYRTGKRENIKSLADD
HVFELDIREYDAVEQIMKTYQFDYVIHLAALVSVAESVEKPILSQEINVV
ATLRLLEIIKKYNNHIKRFIFASSAAVYGDLPDLPKSDQSLILPLSPYAI
DKYYGERTTLNYCSLYNIPTAVVKFFNVFGPRQDPKSQYSGVISKMFDSF
EHNKPFTFFGDGLQTRDFVYVYDVVQSVRLIMEHKDAIGHGYNIGTGTFT
NLLEVYRIIGELYGKSVEHEFKEARKGDIKHSYADISNLKALGFVPKYTV
ETGLKDYFNFEVDNIEEVTAKEVEMS
>SAUSA300_0659 sugar efflux transporter
MDMFAALLQIKNYKLFVANMFLLGMGIAVTVPYLVLFATKDLGMTTNQYG
LLLASAAISQFTVNSIIARFSDTHHFNRKIIIILALLMGALGFSIYFFVD
TIWLFILLYAIFQGLFAPAMPQLYASARESINVSSSKDRAQFANTVLRSM
FSLGFLFGPFIGAQLIGLKGYAGLFGGTISIILFTLVLQVFFYKDLNIKH
PISTQQHVEKIAPNMFKDKTLLLPFIAFILLHIGQWMYTMNMPLFVTDYL
KENEQHVGYLASLCAGLEVPFMIILGVLSSRLQTRTLLIYGAIFGGLFYF
SIGVFKNFYMMLAGQVFLAIFLAVLLGIGISYFQDILPDFPGYASTLFSN
AMVIGQLGGNLLGGAMSHWVGLENVFFVSAASIMLGMILIFFTKNQKITK
EDVIST
>SAUSA300_2451 drug transporter
MINSNIRLYILGFLAFFASLIQNIYTPIIPRLYDDFQVPLFWINATVGGF
IFIVAVMQIVLGRSIDSRDSKKVLLTGLGIVIISSFICAVTHNFILFAIS
RLFQAIGCGIIPLVTLTLLAKLSTDNGRAQAMANYQIFLSCAPALAPILG
STLGARWDYIGIFSFLLVISIVLFLIIFFIDIPNVEKGIVKLTEKIEEKY
LTDKVFITLVTLGFLIFFTYFSILVYLPTLLNNTYDIGVGISGVLFLPIT
VSVILGSLFYKRFSKKYNEIMILRVTITGFAIFTLLFGWLNESNVIILSV
IIFILGTCVGIVPALLSTIISKRFEHIKGKVLGVFNFVRYIGMTVGALLI
GIISQPLVAFYFTTITIMLIVIFLYIKIVDFQLKYAK
>SAUSA300_2472 putative membrane protein
MLLVLSFKGVRYLANNHSALRLKGIILAIVGACLWGLGGTVSDFLFKYKN
INVDWYVTARLVVSGVFLLIMYKMMQPKRSIFSVFQDRRMLGKLLIFSIL
GMLVVQYAYMASINTGNAAIATLLQYIAPVYIIIWFVIRGVAKLTLFDVL
AIIMTLLGTFLLLTNGSFSNLVVNPASLFWGILAGVALAFYTIYPSDLLN
RFGSILIVGWAMLISGVAMNLRHPIWHIDITKWDISIILFLIFGIIGGTA
LAFYFFIDSLQYISAKETTLFGTVEPVVAVIASSLWLHVAFKPFQIVGII
LIMILILLLSLKRQPETLDE
>SAUSA300_1852 putative ABC transporter, ATP-binding protein
MGSSIVLKLLKVTHYYRNKQNKKWYLPFGYDAEDIDLNNISLHIYQGEAL
GIIGEPESSKALVGQLLAGAIKPDKGKVVCTEDLFYGYIEDQSLIHQTVE
AYTAQLVQLFPYEINDHKAEQIIQYAHLGDYKTKPVNHISKAAYAQLLLS
IARSSKSNIIILNHVIDYLTPQFMERAIELTNDYIENNLTIVSIGDDIDK
ISQVSNYIAWFSHGQLRMEGSLKQVIPSFKEHERDRLSLNSKEEIENFDL
DWKKNRTRIPEMTYNFKRVERYNHAKPPKFLVRFWTLASGTILGLALMML
LIFNNIGIISITDFTNRATMQNENKDPYGEKLAYGIAFNGSVDMQGDKQV
TIPKYSVVTITGENSKNYRVTADNKTYYVSKDKLEYFNPAGLYQTHSFKK
LAPYMKSNYSNYYAYFNSQLHKKHSSVIKTLVPDDDNRFVASVTQQPIQL
LFNDNNQLYGFVYPIVDKKELKDKFNINNNIWITKVGNGYCIANLKEDKW
IYIEL
>SAUSA300_2217 putative drug transporter
MTNQGSLNKSPIFTKSFTINFLVNFIVYLCMYLLLVVIAGYSKQAFDASD
SLAGLVVGLFIVGSLIGRFATGKFVNQIGPKRLLFIGLIALIITQLLYFI
DGSLAFLIFVRLINGIATAVVTTATGTIAAYVTPVNRKSEGISLFSLSLV
LGTAIGPFLGMLLITKYAIDLLFIICVILGILGLIISLFIKVDFEVTNNK
TETNVIDKPRFSIHQFIAKEAIPVAVIMLLIGVTYASILTYLQAFALERH
LVTAASYFFICYAIASLITRPIAGRLMDDKNENIIVYPAFIMLFLSFVCL
ISSYQSWLILLAGACLGLGYGNLSSAMQSIAIKVSPPIKYGIATSTFYVG
LDAGVGFGPSFLGLFTHMFSYSEIFGFMAALAIITMLVYFLIHGRHVTRN
AMN
>SAUSA300_0208 putative maltose ABC transporter, ATP-binding protein
MAELKLEHIKKTYDNNNTVVKDFNLHITDKEFIVFVGPSGCGKSTTLRMV
AGLESITSGDFYIDGERMNDVEPKNRDIAMVFQNYALYPHMTVFENMAFG
LKLRKVNKKEIEQKVNEAAEILGLTEYLGRKPKALSGGQRQRVALGRAIV
RDAKVFLMDEPLSNLDAKLRVQMRTEILKLHKRLNTTTIYVTHDQTEALT
MASRIVVLKDGDIMQVGTPREIYDAPNCIFVAQFIGSPAMNMLNATVEMD
GLKVGTHHFKLHNKKFEKLKAAGYLDKEIILGIRAEDIHEEPIFIQTSPE
TQFESEVVVSELLGSEIMVHSTFQGMELISKLDSRTQVMANDKITLAFDM
NKCHFFDEKTGNRIV
>SAUSA300_2379 putative transporter protein
MQSTKTKTKHFSFLLLITLGVMTAFGPLTIDMYVPSLPKVQGDFGSTTSE
IQLTLSFTMIGLALGQFIFGPLSDAFGRKRIAVSILIIFILVSGLSMFVD
QLPLFLTLRFIQGLTGGGVIVIAKASAGDKFSGNALAKFLASLMVVNGII
TILAPLAGGLALSVATWRSIFTILTIVALIILIGVASQLPKTSKDELKQV
NFSSVIKDFGSLLKKPAFIIPMLLQGLTYVMLFSYSSASPFITQKLYNMT
PQQFSIMFAVNGVGLIIVSQVVALLVEKLHRHILLIILTIIQVVGVALII
LTLTFHLPLWVLLIAFFLNVCPVTSIGPLGFTMAMEERTGGSGNASSLLG
LFQFILGGAVAPLVGLKGEFNTSPYMIIIFITAILLVSLQIIYFKMIKKQ
HVA
>SAUSA300_2311 conserved hypothetical protein
MKNLKNSLFISLIIGLSLSLFFSMLFADGKYYPLNPQSTIGILYYTHFTE
TTVMLISIILWLLIGVVFFLGDFIFKYTDWSITKATIMHFITTYVGFLPL
AMLAGWFPLTVHYLIIFTIIFIVVYVLIWIIQFFKNKNYVDTINKQLKQL
K
>SAUSA300_2324 PTS system, sucrose-specific IIBC component
MNYKQSAEEILNAIGGEENLDAMAHCATRLRLVLNDESLVNEEALNNMDV
VKGTFSTGGQYQIIIGSGTVNKVFSELEKLTGKEASTTSEVKAQSAKNMN
PLQRFVKMLSDIFVPIIPAIVAGGLLMGLNNILTAKDLFFSGKSLIDVYS
QFAGLAEMINVFANAPFTLLPILIGFSAAKRFGGNPFLGAALGMILVHPS
LMSAYDFPKAVEAGKAIPYWDVFGLHINQVGYQGQVLPMLVAAYILASIE
KGLRKVIPTVLDNLLTPLLSIFITAFLTFSFVGPITRQLGYWLSDGLTWL
YEFGGAIGGLIFGLLYAPIVITGMHHSFIAVETTLIADATKTGGSFIFPI
ATMSNVAQGGAAIAAFFIIKQNKKLKGVASAAGISALLGITEPAMFGVNL
KLRYPFIGAIVGSGIGSAYIAFFKVKAIALGTAGLPGFISINPVHAGWLH
YFVGMTISFIIAITVTLILSKRKANKEVVE
>SAUSA300_2387 NAD dependent epimerase/dehydratase family protein
MSKIFVTGATGLIGIKLVQRLKEEGHEVAGFTTSENGQQKLAAVNVKAYI
GDILKADTIDQALADFKPEIIINQITDLKNVDMAANTKVRIEGSKNLIDA
AKKHDVKKVIAQSIAFMYEPGEGLANEETSLDFNSTGDRKVTVDGVVGLE
EETARMDEYVVLRFGWLYGPGTWYGKDGMIYNQFMDGQVTLSDGVTSFVH
LDDAVETSIQAIHFENGIYNVADDAPVKGSEFAEWYKEQLGVEPNIDIQP
AQPFERGVSNEKFKAQGGTLIYQTWKDGMNPIK
>SAUSA300_0331 conserved hypothetical protein
MKILVVCGHGLGSSFMVEMNAQEALRQLNAPSDIEVEHSDIMTASPEMAD
LFICGRDLAENAERLGDVLVLDNILDKAELQQKLSEKLQQLNMI
>SAUSA300_0953 putative membrane protein
MTSLKERDYFFDNARAILILLVVFGHMLQPYTSGDKYLSALYLVIYSFHM
PTFLFISGYFAKNIDKPYYLEKISKRLIVPYMIFFAFFSIYYFLTGKSDE
LQLDPFNPVFALWFLITLFFFHVILVIVRRFNPYKVLSVSIIISIGAGFS
DNIDSYLSISRTIVFFPIFYLGYIFTKKHTAIFKNKKLIPVSIITFILFF
IVYVIHPINADWLLGSSPYTSLENEGQSIFSPFKRLILYGIILIAMTAFL
NLMSTKKKLYTYIGSRTLYVYLLHGLIIGIVRGFEWYPFDNPISLMTYLY
LISISVIIVYVLSTNFVCKWTNPIINLQRPSQFKDS
>SAUSA300_0637 dihydroxyacetone kinase, DhaL subunit
MKVNDMKARLLNLEETFKKHESELTELDRAIGDGDHGVNMVRGFSSLKDK
LDDSSMQSLFKSTGMALMSNVGGASGPLYGFSFVKMSAVTKDDMDNQDFI
TLIQAFAEAVESRGKVTLNEKTMYDVVARAAEKLKNGETLTFNDLQQLAD
NTKDMVATKGRAAYFGEESKGYIDPGAQSMVYILNALIGDEDNA
>SAUSA300_0917 putative membrane protein
MERFLYMQDSSLNNYANHKNFILMLIILFLMEFARGMYILSYINFLPTVT
SIAVAITSLAFSIHFIADASTNFVIGFLLKKFGTKIVLTTGFILAFTSLF
LVIWFPASPFVIIFSAMMLGIAVSPIWVIMLSSVEEDKRGKQMGYVYFSW
LLGLLVGMVFMNLLIKVHPTRFAFMMSLVVLIAWILYYFVDVKLTNYNTR
PVKAQLRQIVDVTKRHLLLFPGILLQGAAIAALVPILPTYATKVINVSTI
EYTVAIIIGGIGCAVSMLFLSKLIDNRSRNFMYGVILSGFILYMILIFTL
SMIVNIHILWIIALAIGLMYGILLPAWNTFMARFIKSDEQEETWGVFNSI
QGFGSMIGPLFGGLITQFTNNLNNTFYFSALIFLVLAVFYGSYFIVNREK
AK
>SAUSA300_2434 transporter protein
MLYLEVLKNRNFTYLLIGNFLRRSCFVLFSLQIIWFTVELTNQSSLKLSM
MVMSQTLPFIIFGIFGGAYSDKHNKKKILYLSDLILSLIIIIIPLLAITS
NLNYLTLLTISTAITIINCYTDPAFRAILPEIIDEEHLATSNALIDSLQR
GSNIILPALIGVIVILVGNVGVFFICSILLFLGFIFNALLKYTNNNMIDR
HSKEDFSETWEFLKQSKEIPFIIIIQFACILINTGLWRVVLPLFISNILK
EGVGVYGLATSCLGIASLLMSLIMGLLSEKRLIFKFSIGVLVWGIGLSII
NVFPSVAILYIGATLLGLGQSIEGLTRSVAIQIKTPNHLMGKVFSISSTS
NYAADTLSLGLISIIIPLLSLSNIFILGGVIISILSLAGLKFVKKSM
>SAUSA300_2397 putative transport protein
MSIMRLFTFILSIFIVGMVEMMVAGIMNLMSQDLHVSEAVVGQLVTMYAL
TFAICGPILVKLTNRFSSRPVLLWTLLIFIIGNGIIAVAPNFSILVVGRI
ISSAAAALIIVKVLAITAMLSAPKNRGKMIGLVYTGFSGANVFGVPIGTV
IGDLVGWRYTFLFLIIVSIIVGFLMMIYLPKDQEIQRGPVNHETPSHENH
VTSKILRPAEVAKYLIITFLVLIANSVTFVFINPLILSNGHDMSFVSLAL
LVNGIAGVIGTSLGGIFSDKITSKRWLMISVSIFIVMMLLMNLILPGSGL
LLAGLFIWNIMQWSTNPAVQSGVIQHVEGDTSQVMSWNMSSLNAGIGVGG
IIGGLVMTHVSVQAITYTSAIIGALGLIVVFTLKNNHYAKTFKSS
>SAUSA300_1804 conserved hypothetical protein
MAMNFKVFDNSQLVAEYAADIIRKQFNNNPTTIAGFHLDTDQAPVLDELK
KNVEKHAVDFSQINILDYDDKKSYFEALGVPAGQVYPIAYEKDAIELIAD
KIKTKENKGKLTLQVVSIDEQGKLNVSIRQGLMEAREIFLVVTGANKRDV
VEKLYQENGKTSFEPADLKAHRMVNVILDKEAAAGLPEDVKAYFTSRFA
>SAUSA300_0121 putative drug transporter
MINQSIWRSNFRILWLSQFIAIAGLTVLVPLLPIYMASLQNLSVVEIQLW
SGIAIAAPAVTTMIASPIWGKLGDKISRKWMVLRALLGLAVCLFLMALCT
TPLQFVLVRLLQGLFGGVVDASSAFASAEAPAEDRGKVLGRLQSSVSAGS
LVGPLIGGVTASILGFSALLMSIAVITFIVCIFGALKLIETTHMPKSQTP
NINKGIRRSFQCLLCTQQTCRFIIVGVLANFAMYGMLTALSPLASSVNHT
AIDDRSVIGFLQSAFWTASILSAPLWGRFNDKSYVKSVYIFATIACGCSA
ILQGLATNIEFLMAARILQGLTYSALIQSVMFVVVNACHQQLKGTFVGTT
NSMLVVGQIIGSLSGAAITSYTTPATTFIVMGVVFAVSSLFLICSTITNQ
INDHTLMKLWELKQKSAK
>SAUSA300_0268 putative drug transporter
MNNTQSSPRSNIIIAIMLSALTYWLFAQSFINIGPLVGQTYQTSPAVLNL
SISLTSFATGIFMVAAGDIADKIGQLRMTYMGLIISMFASLLLIISDITA
LLIIGRILQGLSAAILLPSTVGVLNNQFKGEHLRRAISYLMISTVGGIGL
AGVIGGLIASNFGWQTNFIISIVIAFIAILLLKGTPEKVSQHSHRHPFDY
KGMSIFAVMIGSFTLLLTQGFEQGWFSTFSIICLSIFIITTLIFIIIERR
HEVPFIDFSVLRNRPFIGAFLNNFVLNSGLGVTVVFFIYAQTHLGLSAAQ
SGLVTLPYAIVAVAMIRLGEKATLRFGGKLMLIIGPLFPVIGITIISMTQ
LLASQYVIAVIIGFVICAIGNGLVATPGLTIAIFSMPNEKVGLATGLYKM
SGTLGGAFGIALSTTVFSMLQLNYAPSVAATVTFIVSIVLMILGSLSAYM
IIPKTVKS
>SAUSA300_2256 putative N-acetylmuramoyl-L-alanine amidase
MKKNFKLRISTLLLIVILVVFAVLLIVNETKLFKNDVNYSFDEAVSMQQG
KGIVQTKEEDGKFVEANNNEIAKAMTISHKDNDMKYMDITEKVPMSESEV
NQLLKGKGILENRGKVFLEAQEKYEVNVIYLVSHALVETGNGKSELAKGI
KDGKKRYYNFFGIGAFDSSAVRSGKSYAEKEQWTSPDKAIIGGAKFIRNE
YFENNQLNLYQMRWNPENPAQHQYASDIRWADKIAKLMDKSYKQFGIKKD
DIRQTYYK
>SAUSA300_0683 transcriptional regulator, DeoR family
MIITEKRHELILEELSHKDFLTLQELIDRTGCSASTIRRDLSKLQQLGKL
QRVHGGAMLKENRMVEANLTEKLATNLDEKKMIAKIAANQINDNECLFID
AGSSTLELIKYIQAKDIIVVTNGLTHVEALLKKGIKTIMLGGQVKENTLA
TIGSSAMEILRRYCFDKAFIGMNGLDIELGLTTPDEQEALVKQTAMSLAN
QSFVLIDHSKFNKVYFARVPLLESTTIITSEKALNQESLKEYQQKYHFIG
GTL
>SAUSA300_2389 putative drug transporter
MDTSKQFRGDNRLLLGIVLGVITFWLFAQSLVNLVVPLQSTYSSDVGTIN
IAVSLSALFAGLFIVGAGDVADKFGRVKITYVGLILNVVGSLLIIITPLP
AFLIIGRIIQGLSAACIMPSTLAIINEYYIGTRRQRALSYWSIGSWGGSG
ICTLFGGLMATYIGWRSIFVVSILLTLLAMYLIKHAPETKAEPIKGMKAE
AKKFDVIGLVILVVTMLSLNVIITQTSHFGLVSPLILGLIVVFICSLVGF
VYYENKIKHPLVDFSIFKNRGYSGATISNFLLNGVAGGALIVINTYYQQQ
LGFNSSQTGYISLTYLITVLSMIRVGEKILSQHGPKRPLLLGSGFTVIGL
ILLSLTFLPEVWYIISSIVGYLLFGTGLGLYATPSTDTAVASAPDDKSGV
ASGVYKMASSLGNAFGVAVSGTVYTVLAANLNLNLGGFTGMMFNALLAIV
AFLVILLLVPKNQTNL
>SAUSA300_0636 dihydroxyacetone kinase, DhaK subunit
MMKKLINKKETFLTDMLEGLLIAHPELDLIANTVIVKKAKKEHGVAIVSG
GGSGHEPAHAGFVAEGMLDAAVCGEVFTSPTPDKILEAIKAVDTGDGVLL
VVKNYAGDVMNFEMAQELAEMEGINVQTVIVRDDIAVTNEVQRRGVAGTV
FVHKLAGYLAEKGYSLTEIKSRVEALLPEIKSIGMAIEPPLVPTTGKYGF
DIEDDKMEIGIGIHGEKGIHREEVKDIDHIVGTLLDELYKEVTANDVILM
VNGMGGTPLSELNIVTKYIQQNLAARTVNVAKWFVGDYMTSLDMQGFSIT
IVPNKPEYLEAFLAPTTSQYFK
>SAUSA300_2377 glycerate kinase
MQLQKIVIAPDSFKESMTAQQVGNIIKQAFTNVYGNTLHYDIIPMADGGE
GTTDALMHATGATKYTVIVNDPLMRPIEACYARADEQQIAIIEMAAASGL
DLLEKEERNPLYTSSYGTGELIKDALNHGAKTIILGIGGSATNDGGTGML
SALGVKFTDVNGDLLQMNGANLAHIAQIDITNLDSRLKEVTFKVACDVSN
PLLGENGATYIYGPQKGADAKMIPKLDFAMSHYHDKIKMCTGKSVNQIPG
SGAAGGMGAALLAFCETTLTKGIDVVFDITDFHQRIKDADLVITGEGRMD
YQTIFGKTPVGVALAAKQYHIPVIAICGSLGENYQHVYDFGIDSAYSIIS
SPSTLEDVLQNSEQNLLNTATDIARILKLQ
>SAUSA300_0264 ribose transporter RbsU
MSIVALLIGLGPLIGWGFFPTVASKFGGKPVHQIIGATVGTLIFAIILAV
VTSSGLPTGTNLLFALLSGAGWGFGQIITFKAFELVGSSRAMPVTTAFQL
LGASLWGVFALGNWPGIGHKIIGFTALVVILIGARMTVWSERKEASNAKN
LRRAVVLLLIGEFGYWLYSAAPQATSIDGLTAFLPQAMGMVIVAVIYGFM
NMKAENPFRNKITWLQIISGFFFAFGALTYLISAQPNMNGLATGFILSQT
SVVLATLTGIYFLKQHKTSKEMVITIIGLVLILVAASVTVFIK
>SAUSA300_2126 drug resistance transporter, EmrB/QacA subfamily
MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTS
QWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPN
FGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAP
AIGPTATGLIIDQASWRVPFIIILGIAILAFVFGLVSISSYNEVKYTKLD
KRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQF
NITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSA
LLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCF
LHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNF
GRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISF
AFVAVLVMAAYVIALFIREPKEIESNRRKF
>SAUSA300_0124 HPCH/HPAI aldolase family protein
MQQLSLKHRLNNGDSVYGIFNSIPDPLMIEVIAASGYDFVVIDTEHVAIN
DETLAHLIRAAEAAHIIPIVRVTAVIDRDIIKVLDMGARGIIVPHVKDRE
TVEHIVKLSRYYPQGLRSLNGGRMARFGRTPLLDAMEMANEHIMVIAMIE
DVEGVMAIDDIAQVEGLDMIVEGAADLSQSLGIPWQTRDDQVTSHVQHIF
EVVNAHGKHFCALPREDEDIAKWQAQGVQTFILGDDRGKIYRHLSASLAT
SKQKGDEG
>SAUSA300_0311 PfkB family carbohydrate kinase
MSDSEKEILKRIKDNPFISQRELAEAIGLSRPSVANIISGLIQKEYVMGK
AYVLNEDYPIVCIGAANVDRKFYVHKNLVAETSNPVTSTRSIGGVARNIA
ENLGRLGETVAFLSASGQDSEWEMIKRLSTPFMNLDHVQQFENASTGSYT
ALISKEGDMTYGLADMEVFDYITPEFLIKRSHLLKKAKCIIVDLNLGKEA
LNFLCAYTTKHQIKLVITTVSSPKMKNMPDSLHAIDWIITNKDETETYLN
LKIESTDDLKIAAKRWNDLGVKNVIVTNGVKELIYRSGEEEIIKSVMPSN
SVKDVTGAGDSFCAAVVYSWLNGMSTEDILIAGMVNAKKTIETKYTVRQN
LDQQQLYHDMEDYKNGKFTKVY
>SAUSA300_0209 putative maltose ABC transporter, maltose-binding protein
MSKILKCITLAVVMLLIVTACGPNRSKEDIDKALNKDNSKDKPNQLTMWV
DGDKQMAFYKKITDQYTKKTGIKVKLVNIGQNDQLENISLDAPAGKGPDI
FFLAHDNTGSAYLQGLAAEIKLSKDELKGFNKQALKAMNYDNKQLALPAI
VETTALFYNKKLVKNAPQTLEEVEANAAKLTDSKKKQYGMLFDAKNFYFN
YPFLFGNDDYIFKKNGSEYDIHQLGLNSKHVVKNAERLQKWYDKGYLPKA
ATHDVMIGLFKEGKVGQFVTGPWNINEYQETFGKDLGVTTLPTDGGKPMK
PFLGVRGWYLSEYSKHKYWAKDLMLYITSKDTLQKYTDEMSEITGRVDVK
SSNPNLKVFEKQARHAEPMPNIPEMRQVWEPMGNASIFISNGKNPKQALD
EATNDITQNIKILHPSQNDKKGD
>SAUSA300_1993 kinase, pfkB family
MRRLFSIGEALIDFIPNVTNANLKDVQTFTKQIGGAPCNVACTVQKLGQQ
AYMITQLGNDAFGDSIIETISSIGVDVSKVYRTNEANTALAFVSLTEAGE
RDFSFYRKPSADMLFEPSFVNDIDVNENDVVHFCSVDLVDSPMRDAHYQL
ITKTLNANGTVVFDPNVRLPLWDNAEDLRQTIHTFLPLAHIVKVSDEELE
FITGIHDENEAIQSLFTGNVTVVIYTKGADGAAVYLKNGINHYHSGYKVK
PVDTTGAGDAFIGAVISRILATDVLNLTQLFENEGEEILAFSNRVAAIVT
TKYGAINSLPTLQEVEQAF
>SAUSA300_1851 putative membrane protein
MLDNIILYFKNLPHTKRYVTERLKQSWKSFLIVLAACLILIIASETLFSF
SHLTDVKEVRWLFRIIVLIVFAVVMFTIYISYHHYMNDFLVTKLFNISAA
TPVVIMSILSFIMLVILTMISALVKPVNFETSYIALFYFIVMATIFVGLI
SVTFGLIRLLTEKINIIFYGVCVLCFLLLPIIFIPNPNHVFINHILMLNP
MYYIVNGIAQSIIFGISSMENIPYHFYFILFLCLIAAVNFVLARYTTHAI
YNKTSKVTQTDNQQDVSNDSTDEADTSS
>SAUSA300_1691 glutamyl-aminopeptidase
MNINKKVTLQRIQTLTELHGAPGFEEEVKNYMTQQMAPYVDEFIENRMGG
FFGVKKSKNPNAKRVMIAAHMDEIGFMITNITKNGMIQFTNLGGVANDIW
QGQRLVIKNRNGDKIIGVVSNIPKHFRTGSEGAPEIKDLTLDIGAQNEDE
VRERGIDIGDTIVPHTPFTQLSEHRYSAKAWDNRYGCVLAIEILELLKDI
ELDVDLYVGANVQEEVGLRGAKASAEMIDPDVAFVVDCSPANDVKGNQPL
SGELGKGTLIRIKDGTMILKPVFRDYLLKLVEAHDIEHQYYMSPGGTDGG
EIHKANIGIPTAVIGVCARYIHSTDSVFDIRDYFAARSLLSEAICNLDNN
QIETLQYK
>SAUSA300_2156 lactose phosphotransferase system repressor
MNKHERLDEIAKLVNKKGTIRTNEIVEGLNVSDMTVRRDLIELENKGILT
KIHGGARSNSTFQYKEISHKEKHTRQIAEKRFIAKKAASLIEDGDTLFFG
PGTTVELLAEEVNHHTLTIITNCLPVYKILLEKQTAHFRVYLIGGEMRHI
TEAFVGEMANAMLEKLRFSKMFFSSNAVNKGAVMTSTLDEAYTQQLALSN
SIEKYLLIDHTKVGKEDFTSFCQLNELTAVVMDYEDEEKVETIKTYIEVV
D
>SAUSA300_1456 alpha glucosidase
MNKQWWKEAVAYQVYPRSFNDSNHDGIGDLPGMIDKLDYLKDFGIDVIWL
SPMFKSPNDDNGYDISDYQEIMDEFGTMEDFDRLLKGVHDRGMKLILDLV
VNHTSDEHPWFIESKSSKDNPKRDWYIWQDPKPDGSEPNNWESIFNGSTW
EYDANTEQYYFHLFSKKQPDLNWGNPEVRDAVFEMMNWWFDKGIDGFRVD
AITHIKKTFEAGDLPVPEGKTYAPAFDVDMNQPGIQTWLQEMKDRSLSKY
DIMTVGEANGVSPDDADDWVGEENGKFNMIFQFEHLGLWNSGDSHFDVNS
YKSVLNRWQKQLENKGWNALFIENHDQPRRVSTWGDDDKYWYESATSHAA
VYFLQQGTPFIYQGQEIGMTNYPFESIETFNDVAVKNDYQIVKAQGGDVD
ALLAKYKDENRDNSRTPMQWDDTLNGGFTNGEPWFPVNPNYKTINVAQQL
EDEHSVLQFYKDLIQLRKSNDVYVYGQFDLVDAENSQVFAYTRTLNEKQV
LIVGNLTNHEAELTVPFDLSHGEVKLFNYDAKVNLKQLRPYEACVIELN
>SAUSA300_0714 Integral membrane protein
MNPKVKGIIAILISAIGFSFMSVFFRLAGDLPVFQKSLARNLVAMFIPLF
FIYKYHQPMFGRLSSQPLLITRSTLGLIGVLLNIYAIDHMVLSDADSLMK
LNPFWTILLSIVFLHEKVRKYQITAMIIAILGMLLIVKPEFSSSMIPSLA
GLFSGIFAASAYTCVRALSTREAPYTIVFYFSLFSVIVLIPFTAYTYEPM
SQMQILYLLGAGLAAAVGQIGVTLAYSFAAAKDISIFTYASIIFTAILGF
ILFGESPDFYATLGYVVIIGASYYMFEKARRDAKIIKK
>SAUSA300_0236 PTS system, IIBC components
MKSLFEKAQQFGKSFMLPIAILPAAGLLLGIGGALSNPNTVKAYPILDIT
LLQNIFTLMSAAGSIVFQNLPVIFAIGVAIGLSRSDKGTAGLAALLGFLI
MNATMNGLLTITGTLAKDQLAQNGQGMVLGIQTVETGVFGGIITGIMTAI
LHNKYHKVVLPPYLGFFGGSRFVPIVTAFAAIFLGVLMFFIWPSIQAGIY
HVGGFVTKTGAIGTFVYGFILRLLGPLGLHHIFYLPFWQTALGGTLEVKG
HLVQGTQNIFFAQLGDPDVTKYYSGVSRFMSGRFITMMFGLCGAALAIYH
TAKPEHKKVVGGLMLSAALTSFLTGITEPLEFSFLFVAPILYVIHAFFDG
LAFMMADIFNITIGQTFSGGFIDFLLFGVLQGNSKTNYLYVIPIGIVWFC
LYYIVFRFLITKFNFKTPGREDKAAAQQVEATERAQTIVAGLGGKDNIEI
VDCCATRLRVTLHQNDKVDKVLLESTGAKGVIQQGTGVQVIYGPHVTVIK
NEIEELLGD
>SAUSA300_0538 NAD dependent epimerase/dehydratase family
MKKIMITGALGQIGTELVVKCREIYGTDNVLATDIREPEADSPVQNGPFE
ILDVTDRDRMFELVRDFEADSLMHMAALLSATAEKNPILAWDLNMGGLMN
ALEAARTYNLHFFTPSSIGAFGDSTPKVNTPQVTIQQPTTMYGVNKVAGE
LLCQYYFKRFGVDTRSVRFPGLISHVKEPGGGTTDYAVEIYFKAVREGHY
TSFIDKGTYMDMMYMDDAIEAIIKLMEADDAKLETRNGYNLSAMSFDPEM
VKEAIQEYYPNFTLDYDVDPIRQGIANSWPDSIDTSCSRGEWGFDPKYDL
ASMTKLMLEAIEQKDTVKNNN
>SAUSA300_1261 putative glutamyl aminopeptidase
MEPILEMIKTLTGINSPSGDTEEAIQFVEKYAKDLGYQTTLTNKGALLIT
VPGKNDEVQRCITAHVDTLGAMVKEIKEDGRLAIELIGGFTYNAIEGEYC
QIKTDAGQIYTGTICLHETSVHVYRNNHEIPRDQKHMEIRIDEVTTSEED
TKSLGISVGNFVSFDPRTVITSSGFIKSRHLDDKASVAMILQLLKKLKEE
QIILPHTTQFYISNNEEIGYGANASIDSKIKEYIALDMGALGDGQASDEY
TVSICAKDASGPYHKQLKSHLVNLCKINNIPYKVDIYPYYGSDASAALHA
GADIRHGLFGAGIESSHAMERTHIDSIKATEKLLYAYCLSPIE
>SAUSA300_2513 conserved hypothetical protein
MKDILVIGATGKQGNAVVKQLLEDGWYVSALTRNKNNRKLSDIGHPHLSI
VEGDLSDNVSLQSAMKGKYGLYSIQPIVKDDVSEELRQGMKIIEIAEQEN
IQHIVYSTAGGVNRNRTGPHFEVLAKIENRLMESNINATVIKPSFFMDNF
LRIAKVEDERITLPEFINPNIKFTMISSIDIAKIASYIFAHPQSFTHQSI
EIGSDEVTLSEAATIFSEVTGKSTVIEGEFVSGVAEKQWLEEKGYEVDFE
LMAEINPTRLSLSDWLKVQNYNK
>SAUSA300_0240 PTS system, galactitol-specific enzyme II, B component
MKQVLVACGAGIATSTVVNNAIEEMAKEHNIKVDIKQIKITEVGPYEDTA
DLLVTTAMTKKEYKFPVINARNFLTGIGIEETKQQILTELQK
>SAUSA300_1787 HIT family protein
MSETIFGKILTGEIPSFKVYEDDYVYAFLDISQVTKGHTLLIPKKASANI
FETDEETMKHIGAALPKVANAIKRAFNPDGLNIIQNNGEFADQSVFHIHF
HLIPRYENDIDGFGYKWETHEDILDNDAKQQIAEQIQAQF
>SAUSA300_0238 transcriptional antiterminator, BglG family
MNGDNQQILREIVLNPTIHGKELESIFGLSRRQLGYRIQKINLWLEQEGY
PKLERTSQGNFIVSSEIMTLFKRDVSEQQMLNGNNVIFSIETRRYYLMLM
LFSKENAMSLNHFSIDLQVSKNTVIHDINHVKEQLENHGLSLKYSRKHGY
EIVGDEFEVRRFFIKLIDQRLNHDITKSEVLKALNLTFEDIAYQKDKIKQ
VEQFLKSRFIDKSLSSLPYVLCVIRRRIQSGHVMNPLNINYQYLRDTKEY
QATEIMTQHEPDLPEAEKLYLTLHLLSTSVQWTDLQESDSISNLTMAIAQ
MIHHFEQITFINIEDKEKLSQQLLLHLTPAFYRIKYNLTDRDELINPLQG
NYQSLFHMVKQSCQSLTEYFGKSLPDNEIAYLTMLFGGSLRRQDENFDGK
IKAIIVCTQGTSVSQMMLYELRNLFPEIIFLDAISLRTFENYTLDYDIVF
SPMFVLTHKKLFITKVALSENEQRKLRKEVMKYINKESADIDKEINKLMA
LIERTTTVNDITELRDGLEDFIANYNSISTINGSIVTQNKTLDLADLIPA
RHVKRMHHVENIDEAIAKASDVLVANHFIDIKYIHEMQQVFDDSYMVIMQ
NIAIPHAYSEKHVHKTAMSMLILQEPIYMSDGTAIHIIVPIAAVDKVTHL
RALLQLRDVAQDNDAIKRIIQSRKNSDVNEILKNYSNKEARENGWDSN
>SAUSA300_0109 integral membrane domain protein
MNKLQDTTFLSYLFTIILWGSAFPMIKIALNDFSAESLSAFRLILATIIL
LPFVIIKKLPTPELRDIPVIFILGFCGFVIYHTALNFGEALISAGISGIL
VSTTPIFSSALAYIFLKEHFSKWNWLSSLVAFIGISIISISKDDYTTINV
LGVFIILLASFSESLYFTFQKKYIEKYGFIAFTLYTIMASSPFMLIFIPE
IINDIHGATFTSIVSVLYLAIFPTIIPYVLLAYIVKSVGVSDATMSLYLT
PIVSLLLSYLLLDELPTTLAIIGGIITLLGVSLSNFFQNT
>SAUSA300_2449 putative transporter
MKEKRTNVRWMFALAFFFIGVIAYMDRANISYIAKQMMDDLGMTKPQFGL
LASFFSLGYALMQVPSGMLAEKFGPRKMITIALVWWSAFTILTGMIKNHG
LIYLVRFLFGVGEAPMYPSNAVFNSFWFSKNEKGRASSALLAGSYFGPVL
APIVTIAIVNAFNWQAVFYIFGAVGILMAVLWAIIAKDLPEQHRMVNEAE
KRFIMENRDIVATEKSSPPWNDFFKRFSFYAIAIQYFVVQFIITLFLIWL
PTYLTEVFHVNFKEMSISSLPWLLMFFLILSAGAISDRVLGLGRSKFVAR
GVIAIAGFIVFAVSIIFAVRTGNLYVSIFWLSLGLGGIGISMGMSWAAAT
DLGRNFSGTVSGWMNLWGNIGALISPLLAGLFVEHLGWTMTFQLLIVPAV
IAVIMWFYVKPDQPLIVSDDKAIEK
>SAUSA300_0239 PTS system, fructose-specific enzyme II, BC component
MGQQLVHKENIMLNLSATDKESVLSQMSDVLFQNGFVKSTFKDAVIDREK
EFATGLPTHLCSVAIPHTDVEHINHRTIGVAVLEKEVPFIEMGTLDQQTE
VKIVFMLAMDKVDDQLKLLQQLMQIFQSEEKLEQILRTKDETILATLIND
YLEYN
>SAUSA300_0833 conserved hypothetical protein
MKQYKAYLIDLDGTMYMGTDEIDGAKQFIDYLNVKGIPHLYVTNNSTKTP
EQVTEKLREMHIDAKPEEVVTSALATADYISEQSPGASVYMLGGSGLNTA
LTEAGLVIKNDEHVDYVVIGLDEQVTYEKLAIATLGVRNGATFISTNPDV
SIPKERGLLPGNGAITSVVSVSTGVSPQFIGKPEPIIMVKALEILGLDKS
EVAMVGDLYDTDIMSGINVGMDTIHVQTGVSTLEDVQNKNVPPTYSFKDL
NEAIAELEK
>SAUSA300_2614 putative lipoprotein
MHKKYLLLFFLLLSVALLYSCSKQNEKAQNKSVNPNEYAKHKSKMDEHWE
TYHGQVYHVFYHPLITDPKVAFTGDTHQAKGNNDWMITVSEFKKSLNELY
KNNYIIVNPHDVYDLSSHHVKAKKIKLPKGKKPLIISIDDMNYYSYMRHH
GYADRLVLDKNKHVVSETTDKKGHATYSDDNDIVPILNKFVKEHPDFSLN
GEKGVVALTGYEGVLGYRTNELTSKDYTKNKKAAEEVVRAMKRDGWSFAS
HSYGHINFEKTSLEGIKRDTKRWKDEVEPIVGKTDMFVFPHGAQDRHTQA
YDYLVDEAEFKFIAGVGPNNFTDISATNVYQDRVAIDGLNLFEFKYKLKP
FFNPENVYSKQDRRYFKGNRDYEE
>SAUSA300_2433 phosphoglucomutase/phosphomannomutase family protein
MHFHTHLLYNTCEKYCLGAVFFYFWGVFLYNSLHKCKGFSFHVLLSLTEI
LKGCLATMDKELWIERANDSLVKHFYEQQSDIEQREGFESKLTFGTAGIR
GKFGLGEGRLNKFTIEKLALGLARYLNAQTNSPTIVIHYDIRHLSTEFAQ
IIANVLANHQITVYLPDTYKTTPELSFAVRNLNTTAGIMITASHNPKDYN
GIKVYGSDGAQLSTDASELASRYIEEVGDPLQIDIPISKQNTSYIKPFPK
SVTDDYMKHIQNMIGYIPKSDLQVVFTSLHGTSVPIVPELLQSLNFNQFN
LVEAQCKPDPNFSSVQSANPEDHRAFDQAVELANKSHADLLISTDPDADR
LGIAERDAHGHITYFNGNQIGALLLNYRIQQTSQLRHRLMIQSIVSSELT
KSLARYNNVEYKEVLTGFKFIAQEIRQLDDHQNMIFAFEESYGFLSEPFV
RDKDAVQIVPLIIKYASELKLYGKTLKDELEQIYQTVGRHEDTLFSHTLE
GFEGKKKINAIMTKFRSNPPQEIQGLKVKAIEDYLTSEVYHLDKDTTSQI
NSPKSNVIRVLFDEGFIALRPSGTEPKIKLYVSLKCPNFDDVAQKINAMI
FS
>SAUSA300_1725 transaldolase
MAKLNIEVFADGADIEEMKAAYKNKQVDGFTTNPSLMAKAGVTDYKAFAE
EAVKEIPDASISFEVFADDLETMEKEAAILKQYGENVFVKIPIVNTKGES
TIPLIKKLSADNVRLNVTAVYTIEQVKEITEAVTEGVPTYVSVFAGRIAD
TGVDPLPLMKEAVKVTHSKDGVKLLWASCRELFNVIQADEIGADIITCPA
DVVKKVNTNLGRDINELSVDTVKGFAKDIQSSGLSIL
>SAUSA300_2621 conserved hypothetical protein
MSQQDLPTLFYSGKSNSAVPIISESELQTITAEPWLEISKKGLQLEGLNF
DRQGQLFLLDVFEGNIFKINPETKEIKRPFVSHKANPAAIKIHKDGRLFV
CYLGDFKSTGGIFAATENGDNLQDIIEDLSTAYCIDDMVFDSKGGFYFTD
FRGYSTNPLGGVYYVSPDFRTVTPIIQNISVANGIALSTDEKVLWVTETT
ANRLHRIALEDDGVTIQPFGATIPYYFTGHEGPDSCCIDSDDNLYVAMYG
QGRVLVFNKRGYPIGQILIPGRDEGHMLRSTHPQFIPGTNQLIICSNDIE
MGGGSMLYTVNGFAKGHQSFQFQ
>SAUSA300_2641 conserved hypothetical protein
MKLTLMKFFVGGFAVLLSYIVSVTLPWKEFGGIFATFPAVFLVSMFITGM
QYGDKVAVHVSRGAVFGMTGVLVCILVTWMMLHMTHMWLISIVVGFLSWF
ISAVCIFEAVEFIAQKRLEKHSWKAGKSNSK
>SAUSA300_0316 ROK family protein
MYYIAIDIGGTQIKSAVIDKQLNMFDYQQISTPDNKSELITDKVYEIVTG
YMKQYQLIQPVIGISSAGVVDEQKGEIVYAGPTIPNYKGTNFKRLLKSLS
PYVKVKNDVNAALLGELKLHQYQAERIFCMTLGTGIGGAYKNNQGHIDNG
ELHKANEVGYLLYRPTENTTFEQRAATSALKKRMIAGGFTRSTHVPVLFE
AAEEGDDIAKQILNEWAEDVAEGIAQIQVMYDPGLILIGGGISEQGDNLI
KYIEPKVAHYLPKDYVYAPIQTTKSKNDAALYGCLQ
>SAUSA300_0554 glucosamine-6-phosphate isomerase
MKVLNLGSKKQASFYVACELYKEMAFNQHCKLGLATGGTMTDLYEQLVKL
LNKNQLNVDNVSTFNLDEYVGLTASHPQSYHYYMDDMLFKQYPYFNRKNI
HIPNGDADDMNAEASKYNDVLEQQGQRDIQILGIGENGHIGFNEPGTPFD
SVTHIVDLTESTIKANSRYFKNEDDVPKQAISMGLANILQAKRIILLAFG
EKKRAAITHLLNQEISVDVPATLLHKHPNVEIYLDDEACPKNVAKIHVDE
MD
>SAUSA300_2298 multidrug resistance protein B, drug resistance transporter
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKF
KASDLDKTTDQSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTN
NKDEEAVAAKNPESEEYKVNEKIKKEHKNFIFGEGVSRGKILAALLFGMF
IAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPITAYLFN
KYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAIGAGVLMPLGS
IVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILIGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGN
KGWGSVEIETMFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTII
NMVVMLSLYGGMILLPIYLQNLRGFSALDSGLLLLPGSLIMGLLGPFAGK
LLDTIGLKPLAIFGIAVMTYATWELTKLNMDTPYMTIMGIYVLRSFGMAF
IMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAILVTVMTTQTTQ
HLSAFGEELDKTNPVVQDHMHELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLDADNSINHE
>SAUSA300_2097 conserved hypothetical protein
MNILVIGANGGVGSLLVQQLAKENVPFTAGVRQSDQLNALKSQGMKAILV
DVENDSIETLTETFKPFDKVIFSVGSGGNTGADKTIIVDLDGAVKSMIAS
KEANIKHYVMVSTYDSRRQAFDDSGDLKPYTIAKHYADDYLRRSGLNYTI
LHPGALTNAAGSGKIEAAQYFDGKGEIPREDVATVLKEIVTSNHFNHQEF
QIISGDQDIKDALTQFENETD
>SAUSA300_0007 conserved hypothetical protein
MGGYITMETLNSINIPKRKEDSHKGDYGKILLIGGSANLGGAIMLAARAC
VFSGSGLITVATHPTNHSALHSRCPEAMVIDINDTKMLTKMIEMTDSILI
GPGLGVDFKGNNAITFLLQNIQPHQNLIVDGDAITIFSKLKPQLPTCRVI
FTPHLKEWERLSGIPIEEQTYERNREAVDRLGATVVLKKHGTEIFFKDED
FKLTIGSPAMATGGMGDTLAGMITSFVGQFDNLKEAVMSATYTHSFIGEN
LAKDMYVVPPSRLINEIPYAMKQLES
>SAUSA300_0394 FAD/NAD(P)-binding Rossmann fold Superfamily
MNIMLTGATGHLGTHITNQAIANHIDHFHIGVRNVEKVPEDWRGKVPVRQ
LDYFNQESMVEAFKGMDTVVFIPSIIHPSFKRIPEVENLVYAAKQSGVAH
IIFIGYYADQHNNPFHMSPYFGYAARLLATSGIDYTYVRMAMYMDPLKPY
LPELMNMHKLIYPAGDGRINYITRNDIARGVIAIIKNPDTWGKRYLLSGY
SYDMKELAAILSEASGTEIKYEPVSLETFAEMYDEPKGFGALLASMYDAG
ARGLLDQESNDFQQLVNDQPQTLQSFLQENI
>SAUSA300_0180 integral membrane protein LmrP
MKRLSTTLKVRLISNFLQLIITTAFIPFIALYLTDMLSQSIVGIYLVGLV
VLKFPLSIISGYLIEIFPKKLLVLIYQATMVIMLVFMGVFGSHQLWQIIG
FCVAYAIFTIVWGLQFPVMDTLIMDAITEDVEHYIYKISYWMTNLSVAIG
ALLGGLMYGYSMLLLFLIAACIFLIVLFILYIWLPQDRNQVKQSDDKRHA
SRYQKLQIMNIFRSYKLVLKDRNYMLLISGFSIIMMGEFSISSYIAIRLK
DQFETISIGSYDITGAKMLAILLMINTVVVILLTYSISKVVLKIDFKKAL
ITGLLIYIVGYSGLTYLNQFGLLVVFMIIATVGEIIYSPIVSEQRFKIIP
KAKRGTYSAVNALGIHFSETLARLGIVLGVFLTSLQMGLYMFIVLTIGAS
MLVAGVFGGQKQVNTN
>SAUSA300_2128 putative drug transporter
MRLKSIITVIALILIMFMSAIESSIISLALPTIKQDLNAGNLISLIFTAY
FIALVIANPIVGELLSRFKIIYVAIAGLLLFSIGSFMCGLSTNFTMLIIS
RVIQGFGSGVLMSLSQIVPKLAFEIPLRYKIMGIVGSVWGISSIIGPLLG
GGILEFATWHWLFYINIPIAIIAIILVIWTFHFPEEETVAKSKFDTKGLT
LFYVFIGLIMFALLNQQLLLLNFLSFILAIVVAMCLFKVEKHVSSPFLPV
VEFNRSITLVFITDLLTAICLMGFNLYIPVYLQEQLGLSPLQSGLVIFPL
SVAWITLNFNLHRIEAKLSRKVIYLLSFTLLLVSSIIISFGIKLPVLIAF
VLILAGLSFGYIYTKDSVIVQEETSPLQMKKMMSFYGLTKNLGASIGSTI
MGYLYAIQSGIFGPNLHNVLSAVAVISIGLIVLWVVFFKEQSSQSKE
>SAUSA300_0104 transcriptional regulator, AraC family
MSDFKRLNSLMIGFVIKGEAHIYDENNMTQCNSGDIFIINHRDLYRFQLQ
QDGIICYIQFQMKYLADKFDDVHCLYFHLTDATTTKNIHQLRNIMARLVS
THIRHNELSKLTEQQLVIQLLMHMIHYVPRTYHSNQSILNDDKVNQVCDY
IELHFHEDLSLSELSEYVGWSESHLSKKFTESLGVGFHHFLNTTRIEHAK
LDLTYTDETITDIALQNGFSSAASFARTFKHFTHQTPKQYRGDRPAITEN
QQSAQHDYHDRELILLLNDYIEEMNHFIEDIEKMNYKEIAFQPTNHQLNQ
FNHIIQVGYLRNLLNTQYQSQLLTCHHDFQVNEVLAYDVIPYIMKKLNAP
FTYDAEISNIFYDIDLCLDFLLDHNFSLTMHLDQYDSRDYIDAFKIFIHH
VALHVSHRKDLKFNLYVTTLHTSLIEMIDYFKALFPNGGLYIHLDQATER
HLPLLKRLEPHIDHFVFDANSNDAVDFNKMNDDEFKTASQMIINKTNYLI
DLMHRHRLKRPLILLNWNTLTGDTFITNGEYFRGGIIIEQLLKLSSKVEG
IGYWLNYDLHVSHCKNERDYMNSIELFHQYNGKRPVYFTALLFNKLTSNI
LYSDDTCIVTGTDSNFQILLYDAKHFNPYLALDNQMNMRATEMIHLNINA
LEEGMYKIKHFTLDKENGALFNLWRKHHTIHGMDKDSIDYVNRMSFPKLE
VYDIDITDTLALNIKMITNGIHLIEVKRYPSS
>SAUSA300_2085 conserved hypothetical protein
MSYKAYPFFRDILINECIYFASKNKKLVRLNYKSEAYVGVWTEESVAVSF
LTSRDIPFDKVVKMDVDRFATYELDELFDEQDHIIMNQTMEEEGHLLNVV
AVTQEVMTELDKIRIKEFVQDVAKYDEVYGLTKKGSKQFILISENDSDEK
KPHIMPVWSIKNRALKVRDEDFEECDLITIEGSVFGEWLDELRDDHKAVA
IDLKTGVVGTIVSAQKLSNELTF
>SAUSA300_2400 glutamyl-aminopeptidase
MNQSVKLLKHLTDVNGIAGYEMQVKEAMRNYIEPVSDQIIEDNLGGIFGK
KNAENGQYSIMISGHMDEVGFMVTKIDKHGFISFTPVGGWWNQVMLSQKV
TITTDSGKEIRGIIGSKPPHVLTPEERKKPMEIKNMFIDIGVSSKEEAEE
AGVEVGNMVTPYSEFEVLANDKYLTAKAFDNRYGCALAIEVLKRLKDENI
GINLYSGATVQEEVGLRGAKVAANTIKPDLAIAVDVGIAYDTPGMSGQTS
DSKLGGGPVVIMMDATSIAHQGLRKHIKDVAKEHNIEVQWDTTPGGGTDA
GSIHVANEGIPTMTIGVTLRYMHSNVSVLNVDDYENSIRLVTEIVRSLND
ESYKNIMW
>SAUSA300_0333 transcriptional antiterminator, BglG family
MLSYRQIEILYLLIHEQTFIPINTIANQLGVSPRTIQYDIAYIEQYAETY
HYQVSRNKAAGIKVTTAHATLLNELEHNLTNQIHFSKDERLTHIALKLFE
TTDPVSTKQLAQDVNVSRRTIADDIKMIQAQLDQYHLKLNYVHNKGFNII
GEEDHYRKAYAHFIHQYMKQAAPFIEADIFNSESIALVRRAIIKTLNSEN
YHLVQSAIDGLIYHILIAIQRLNENFSFDIPINEIDKWRHTNQYAIASKM
IENLERSCNVTFPESEIIFITLHLLGSKMTEHTASSITFEYHDLSQNIHE
LITCVSQELGIDMSKDNKLHTSLITHIKPAIHRIKYDMLQPNPLRQEVMR
RYPQIIEAVSKHISPIEQDAAIRFNEDELTYITIHFASSIERVATHKQSM
IKVVLLCGSGIGTSQLLKSKLNHLYPEFHIWDAYSIYQLEESRLLQDNID
YVISTVPCEISAVPVIHVDPFINQQSRQKLNQIINDSREQRVMKMATDGK
SLADLLPEHRIIINKQPLSIESAIAVAVQPLINDGIVYSNYTAAILKQFE
QFGSYMVISPHIALIHAGTDYVQNGVGFALTYFTEGIIFGSKANDPVHLV
ITLATDHPNAHLKALGQLSECLSNDLYRQDFLDGNIFKIKQHIALTMTKE
A
>SAUSA300_0329 putative oxidoreductase
MNNKVLATGGTGFVGMRIISRLLEQGYDVQTTIRDLSKADKVIKTMQDNG
ISTERLMFVEADLSQDEHWDEAMKDCKYVLSVASPVFFGKTDDAEVMAKP
AIEGIQRILRAAEHAGVKRVVMTANFGAVGFSNKDKNSITNESHWTNEDE
PGLSVYEKSKLLAEKAAWDFVENENTTVEFATINPVAIFGPSLDAHVSGS
FHLLENLLNGSMKRVPQIPLNVVDVRDVAELHILAMTNEQANGKRFIATA
DGQINLLEIAKLIKEKRPEIAQKVSTKKLPDFILSLGAKFNHQAKEGKLL
LDMNRNVSNERAKTLLGWEPIATQEEAILAAVDSMAKYHLI
>SAUSA300_2406 putative transporter
MKGAMAWPFLRLYILTLMFFSANAILNVFIPLRGHDLGATNTVIGIVMGA
YMLTAMVFRPWAGQIIARVGPIKVLRIILIINAIALIIYGFTGLEGYFVA
RVMQGVCTAFFSMSLQLGIIDALPEEHRSEGVSLYSLFSTIPNLIGPLVA
VGIWNANNISLFAIVIIFIALTTTFFGYRVTFAEQEPDTSDKIEKMPFNA
VTVFAQFFKNKELLNSGIIMIVASIVFGAVSTFVPLYTVSLGFANAGIFL
TIQAIAVVAARFYLRKYIPSDGMWHPKYMVSVLSLLVIASFVVAFGPQVG
AIIFYGSAILIGMTQAMVYPTLTSYLSFVLPKVGRNMLLGLFIACADLGI
SLGGALMGPISDLVGFKWMYLICGMLVIVIMIMSFLKKPTPRPASSL
>SAUSA300_1705 putative drug transporter
MNIPKSVWWLVIGMALNITGSSFLWPLNTIYMKQELGKSLTVAGLVLMIN
SFGMVIGNLLGGSLFDKLGGYKTILIGTFTCLCSTTLLNFFHGWPWYAVW
LVMLGFGGGMIIPAIYAMAGAVWPNGGRQTFNAIYLAQNIGVAVGAAMGG
FVAEFSFNYIFLANLIMYVVFALVAVTQFNIEINAKVKYPTHLDITGKKN
KARFISLVLICAMFAICWVAYIQWESTIASFTQSINISMAQYSVLWTING
IMILVAQPLIKPILYLLKGNLKKQMFVGIIIFMLSFFVTSFAENFTIFVV
GMIILTFGEMFVWPAVPTIANQLAPDGKQGQYQGFVNSAATVGKAFGPFL
GGVLVDAFNMRMMFIGMMLLLVFALILLMVFKENNTQPKKIDA
>SAUSA300_0980 putative membrane protein
MSFLRKHAEIIFSYLIGIVSLFTGLIILINLPLIKQLNGGKKVDTHVHNV
WEFLNAFFSEIIKVMSRFIGDFPIVSAIVIIIFGILVMLIGHTLLRTIKY
DYDISIFFLVIGIMYFIITLILMTQVYGFFAVIFIIPFTIHIGYIVYKDE
LNQENVKNHFMWIIVSYGISYLITQIALYGRIDANEIESIDILSVNAFFI
IMWLLGQMAIWNFLFLRRALPLTKQELGEEEPELSRTSKGNVTNQTKIHL
KQLQDKTTEYARKTRRSVDLDKIRAKRDKFKKKVNDIIDIQEDDIPDWMR
KPKWVKPMYVELFCGVVIFLFTFLEFNNRNALFVSGDWKLSQTQYVIEWV
TLLILLFIIIAYIATTLTFHLKGKFYYLQLFMGSILFFKLLTEFINIMIH
GLLLSVFITPTLLLMLLAIIISYSLQLRERP
>SAUSA300_0259 PTS system, IIA component
MSNKYKEQAQDILTAVGGVENIVDATYDTKCITIHMQHTIPSTANEVKQI
VDVTSVAENDTQLVIKLNGNVDEVYQQLQRLIKNANVEESENTDNINSQD
TSYTPQVKVTTPILVKAPIAGRRILLKEVRDSIFREKMVGEGLAIKAHEE
SKVIAPFNGLISMIVPTKHAVGIQSEDGVDIVIHIGLNTVDLEGKGFKCF
VKQNDHVEAGQTLLQFDQQYIQQQGYNADVIVVISNSADLGKVELTMNEI
ITTEDVIFKIFKN
>SAUSA300_0332 PTS system, IIA component
MSLDILSTTRIIVKEQVNDWTEAITIASQPLLQEQIIEQGYVQAMIDSVN
ELGPYIVIAPEIAIAHARPNNDVHQVGLSLLKLNQHVAFCDEDHYASLIF
VLSAIDNHSHLSVLQNLATVLGDNQTVQQLLTATNAQDIKNILKEHD
>SAUSA300_2139 putative transporter
MTKYFFSSSFLLFLGNWIGQIGLNWFVLTTYHNAVYLGIVNFCRLVPILL
LSVWAGAIADKYDKGRLLRITISSSFLVTAILCVLTYSFTAIPISVIIIY
ATLRGILSAVETPLRQAILPDLSDKISTTQAVSFHSFIINICRSIGPAIA
GVILAVYHAPTTFLAQAICYFIAVLLCLPLHFKVTKIPEDASRYMPLKVI
IDYFKLHMEGRQIFITSLLIMATGFSYTTLLPVLTNKVFPGKSEIFGIAM
TMCAIGGIIATLVLPKVLKYIGMVNMYYLSSFLFGIALLGVVFHNIVIMF
ICITLIGLFSQWARTTNRVYFQNNVKDYERGKVLSIIMMDRGMIPLGSLL
MSICADVFGIVRTFSIMGISTICITMVFYFINRKLKLKLEESNHGIS
>SAUSA300_0881 putative membrane protein
MNKLILGIYLYRIFSRAYFYLPFLLIYFLIQGYSIIQLEILMASYGIAAF
LFSLYKEKCFKICNLKDSNKLVVSEIFKIIGLLLLLYQNQYLILVVAQIL
LGLSYSMMAGVDTAIIKRNITNEKYVQNKSNSYMFLSLLISGIIGSYLYG
INIKWPIIMTGIFSILTIIIIRCTLVENRELNLIGETKGKIKKFLPEEKF
WILHYSFLRALILGFFIGFIPINIYNDLKLNNLQFISVLTCYTVMGFVSS
RYLTKYLNYKFVSEICLVIFLIIYTYQSFIAVTISMIFLGISSGLTRPQT
INKLSSSSNLRVMLNYAETLYFIFNIAFLLMGGYLYTIGTIQYLILFISL
LIFIYLIIIFYFTRREQHENKN
>SAUSA300_2525 conserved hypothetical protein
MNEQWLEHLPLKDIKEISPVSGGDVNEAYRVETDTDTFFLLVQRGRKESF
YAAEIAGLNEFERAGITAPRVIASGEVNGDAYLVMTYLEEGASGSQRQLG
QLVAQLHSQQQEEGKFGFSLPYEGGDISFDNHWQDDWCTIFVDKRLDHLK
DELLNRGLWDANDIKVYDKVRRQIVAELEKHQSKPSLLHGDLWGGNYMFL
QDGRPALFDPAPLYGDREFDIGITTVFGGFTSEFYDAYNKHYPLAKGASY
RLEFYRLYLLMVHLLKFGEMYRDSVAHSMDKILQDTTS
>SAUSA300_0318 N-acetylmannosamine-6-phosphate 2-epimerase
MLPHGLIVSCQALPDEPLHSSFIMSKMALAAYEGGAVGIRANTKEDILAI
KETVDLPVIGIVKRDYDHSDVFITATSKEVDELIESQCEVIALDATLQQR
PKETLDELVSYIRTHAPNVEIMADIATVEEAKNAARLGFDYIGTTLHGYT
SYTQGQLLYQNDFQFLKDVLQSVDAKVIAEGNVITPDMYKRVMDLGVHCS
VVGGAITRPKEITKRFVQIMED
>SAUSA300_2575 transcriptional antiterminator, BglG family
MLDRHLKLLQFFIKNPSKHISSNEIAKHVNVSNRTVRNDIHVINSNFMDD
IIVSIKSKGYQLNTSQYTLETITERYTHIQSYKEKLLLSMAYQLLMHNKS
QTLQQLEQDYLLSKTVLNDYFVRIQQWCQKFNIALTIKKKQGIVVDGTDN
DITNAIIHLNQLSSGHVHVEDLILNELPDSHQRMISHIIQETLQQHSIET
TDIQIQQLLIHLILIIKRKQSLSELDTLNHDSKLISQSCIKQINERLGYD
LNEKVINMFSFFIAYHFNKLDIGIERIFIQSYIDRLIELMQQRIHVPFNE
DSILQQNLYNHFSKAYLRITQNIYLNNPLVIEIKKLYPFVFNTLFEAIDK
LAIDTDIEMSEDEIAFLTIHFQAAIERRTKTQLNVVIACYYGLGVSNFLE
TKINNLSEELSVINTIKLENITHYHFDNVDLLITTHDIPKQTLNILPKHL
TTIKVAPLFSEDDRHKIRHVVKQKQNPVQAHHHMDTVNFLVVNTEQKSRH
TVQIFEEAQKILQAHHAIVEGYIESALEREKSSSTYIGNFMAIPHGDPEK
VLQSHVLIFRTKDVFPWRQHDVKLVFFLAISHKDKAFTKQMMQLIANLDD
DSVNHLCSLDDHSLKQQLFEYLQE
>SAUSA300_2360 multidrug resistance protein
MTALPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQVFL
VGISIFFLGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQP
HERGKYMGIFGLVIGLAPAIGPTLSGYLVEYFNWRSLFHVVAPIAAVTFL
IGFKTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTSSISEKGFDNPIVL
VSMIGGVVLVALFVLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMI
GSETILPIFVQNLLHRSALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRN
LALVGMAIVVITTAYFVVMDEQTSTIMLATVYAIRMVGIALGLIPVMTHT
MNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMSDYN
GMNKIDMMNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDS
RQ
>SAUSA300_0139 putative tetracycline resistance protein
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQ
ATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFP
LLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVI
GTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVG
LILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFF
QNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVIS
MIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIA
AALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVSLNRWTQSEK
>SAUSA300_0375 putative phosphoglycerate mutase family protein
MTIYLVRHGESKSNYDNKHFRSYFCGQLDVPLTDTGTKSADDLCDYFKEK
QIKHVYVSDLLRTQQTFEHIFPYDIASTTTPLLRERSLGVFEGEYKDEIS
ANPKYEKYFNDPNFKDFRHSFSQKAPEGESYEDVYQRVEHFMNHVVNEDT
QKDDIVIVAHQVVIRCLMVYFNKVSRAEAVDLKVENCKPYIIE
>SAUSA300_0555 putative hexulose-6-phosphate synthase
MELQLAIDLLNKEDAAELANKVKDYVDIVEIGTPIIYNEGLPAVKHMADN
ISNVKVLADMKIIDAADYEVSQAIKFGADVITILGVAEDASIKAAIEEAH
KNNKQLLVDMIAVQDLEKRAKELDEMGADYIAVHTGYDLQAEGQSPLESL
RTVKSVIKNSKVAVAGGIKPDTIKDIVAESPDLVIVGGGIANADDPVEAA
KQCRAAIEGK
>SAUSA300_2260 inositol monophosphatase family protein
MTDKTLQQIDKLICSWLKQIDNVIPQLIMEMTTETKRHRFDLVTNVDKQI
QQQFQQFLATHFPEHQLLAEEKSNEMITNEINHLWIMDPIDGTANLVKQQ
EDYCIILAYFYEGKPMLSYVYDYPHKKLYKAIRGEGAFCNGIKMEEPPSL
KLEDAIISFNAQVMNLDTVQDLFDASFSYRLVGACGLDSMRVAKGQFGAH
INTNPKPWDIAAQFLFAELLNLKMTTLDGKAIDHLKGAPFIISNKACHET
VLKILNANGGYQKYR
>SAUSA300_2130 UTP-glucose-1-phosphate uridylyltransferase family protein
MLDKNQLAKYKQDHLCEYEKIMSNNEKEALEEKVASLDLDFIAKLYNDLY
INKKTIDDVSAVSEVKYDIKSQMSDDEIKRLEEQGLQAIKEGQFAVLLMA
GGQGTRLGYKGPKGSFEIEGVSLFELQANQLKTLNHQSGHTIQWYIMTSD
INHEETLAYFEAHSYFGYDQEAIHFFKQDNIVALSEEGKLILNQQGRIME
TPNGNGGVFKSLDKAGYLEEMSNNGVKYIFLNNIDNVLVRVLDPLFAGFT
VEHDYDITSKTIQPKPGESVGRLVNVDCKDTVLEYSELDPEVANQFNNAN
IGIHAFKLGFILNAVNRELPYHLAIKNLKQLDENFGVIEQPTLKFELFYF
DIFTYGTSFVTLQVPREEEFSPLKNKEGKDSVATATEDLRRMGLI
>SAUSA300_2106 putative transcriptional regulator
MLLSTREKEMIALLIKYHGQYITIHDIAQQLAVSSRTIHRELKGVEAYLT
SFSLTLERANKKGLRIAGTDSDLNDLKQSIAQHQTIDLSVEEQKVIIIYA
LIQAKEPVKQYSLAQEIGVSVQTLAKMLDDLELDLNKYQLSLSRKRGEGI
YLVGTESKKREFLSQLMVNNLNSTSVYSVIENHFVFHSLNQIHKDFVDLE
RIFNVERLLMDYLSALPYQLTESSYLTLTVHIVLSISRIKNGEYVALNDD
IYDSVQNTFEHKVASELADKLGQIYDVTFNQAEIAFITIHLRGAKRKNLN
DTSLNNRCEENKIKAFVNKVEMISGMTFADLDTLVDGLTLHLNPAINRLQ
ANIETYNPLTDMIKFKYPRLFENVRLALNDCWPDLIFPESEIAFIVLHFG
GSIKNQGNRFLNILVVCSSGMGTSRLLSTRLDQVFSEIERITQASVSDLK
SLDLSQYDGIISTVNLDIDSPYLTVNPLLPDSDISYVAQFLNTKSTFQET
HDKSSNMIDKDDVHVETKDVDGNTSFENEQTSYLTSVFEKHLSDEKSEQL
LHHMRSGLTLLDSVKIVSTEVKQWQTYIADYLYQCDVINDPTSFAELLEQ
RLIDNPGWILSPYPVAIPHLRDNMIKHPMILITVLEEPLTLPSIQNDNQT
IKYMISMFISDNDFMASLVSDLSEFLSLKLESIDTFMENPQELETLLRNK
FLERIKKQFI
>SAUSA300_2540 fructose-bisphosphate aldolase class-I
MNKEQLEKMKNGKGFIAALDQSGGSTPKALKEYGVNEDQYSNEDEMFQLV
HDMRTRVVTSPSFSPDKILGAILFEQTMDREVESKYTADYLADKGVVPFL
KVDKGLAEEQNGVQLMKPIDNLDNLLDRANERHIFGTKMRSNILELNEQG
IKDVVEQQFEVAKQIIAKGLVPIIEPEVNINAKDKAEIEKVLKAELKKGL
DSLNADQLVMLKLTIPTEPNLYKELAEHPNVVRVVVLSGGYSREKANELL
KDNAELIASFSRALASDLRADQSKEEFDKALGDAVESIYDASVNKN
>SAUSA300_1720 conserved hypothetical protein
MNKHKKGSIFGIIGLVVIFAVVSFLFFSMISDQIFFKHVKSDIKIEKLNV
TLNDAAKKQINNYTSQQVSNKKNDAWRDASATEIKSAMDSGTFIDNEKQK
YQFLDLSKYQGIDKNRIKRMLVDRPTLLKHTDDFLKAAKDKHVNEVYLIS
HALLETGAVKSELANGVEIDGKKYYNFYGVGALDKDPIKTGAEYAKKHGW
DTPEKAISGGADFIHKHFLSSTDQNTLYSMRWNPKNPGEHQYATDIKWAE
SNATIIADFYKNMKTEGKYFKYFVYKDDSKHLNK
>SAUSA300_2282 putative membrane protein
MKNNKISGFQWAMTIFVFFVITMALSIMLRDFQSIIGVKHFIFEVTDLAP
LIAAIICILVFKYKKVQLAGLKFSISLKVIERLLLALILPLIILIIGMYS
FNTFADSFILLQSTGLSVPITHILIGHILMAFVVEFGFRSYLQNIVETKM
NTFFASIVVGLMYSVFSANTTYGTEFAAYNFLYTFSFSMILGELIRATKG
RTIYIATTFHASMTFGLIFLFSEEIGDLFSIKVIAISTAIVAVGYIGLSL
IIRGIAYLTTRRNLEELEPNNYLDHVNDDEETNHTEAEKSSSNIKDAEKT
GVATASTVGVAKNDTENTVADEPSIHEGTEKTEPQHHIGNQTESNHDEDH
DITSESVESAESVKQAPQSDDLTNDSNEDEIEQSLKEPATYKEDRRSSVV
IDAEKHIEKTEEQSSDKNK
>SAUSA300_2455 putative fructose-1,6-bisphosphatase
MTQITEKELKKKYLDLLSQNFDTPEKLATEIINLESILELPKGTEHFVSD
LHGEYEAFQHVLRNGSGNVRAKINDIFKERLSTKELNDLTALVYYPEDKL
KLIKSDFQNCGQLNVWYITTIEHLIELIKYCSSKYTRSKLRKALPKQYVY
IIEELLYKSNEYQNKKSYYETLVNQVIELKQADDLIIGLAYSVQRLVVDH
LHVVGDIYDRGPQPDKIMDTLINYHSLDIQWGNHDVLWVGAYAGSKVCLA
NLLRICARYDNLDIIEDAYGINLRPLLTLAEKYYDADNPAFKPKKRPDKH
ERLTQREESQITKIHQAIAMIQFKLEIPIIKRRPNFEMEERLVLEKVNYD
TNEITVYGNTYPLKDTCFQTVNRDNPAELLPEEEEVMNKLLLSFQQSEKL
RRHMSFLMRKGSLYLPYNGNLLIHGCIPVDENGEMESFEIDGHTYSGQEL
LDVFEYHVRKSFDEKENTDDLSTDLVWYLWTGKYSSLFGKRAMTTFERYF
IADKASHKEEKNPYYHLREDVNMVRKMLSDFGLNPDEGRIINGHTPVKEI
NGEDPIKADGKMLVIDGGFSKAYQSTTGIAGYTLLYNSFGMQLVAHQQFN
AKEKILSEGIDELSIKRVVDKELQRKKIRDTNIGKDLQAQIDILKMLMHD
RYLD
>SAUSA300_0726 glycerate kinase family protein
MKVLVAMDEFHGIISSYQANRYVEEAVASQIETADVVQVPLFNGRHELLD
SVFLWQSGQKYRIPVHDADMNEVEGVYGQTDTGMTVIEGNLFLKGKKPIV
ERTSYGLGEMIKHALDNDAKHVVISLGGIDSFDAGAGMLQALGAQFYDDE
GRVVDMRQGAGVIKYIRRMDMSNLHPKMETARIQVMSDFSSRLYGKQSEI
MQTYDAYQLNHNQAAEIDNLIWYFSELFKSELKIAIGPVERGGAGGGIAA
VLNGLYQAEILTSHALVDQLTHLENLVEQADLIIFGEGLNENDQLLETTT
LRIAELCHKHQKVAIAICATAEKFDLFESQGVTAMFNTFIDMPETYTDFK
MGLQIRHYTVQSLKLLKTHFNVEV
>SAUSA300_0214 conserved hypothetical protein
MKIGVFSVLFYDKNFEDMLDYVSESGLDMIEVGTGGNPGDKFCKLDELLE
NEDKRQAFMKSITDRGLQISGFSCHNNPISPDPIEAKEADETLRKTIRLA
NLLDVPVVNTFSGIAGSDDTAKKPNWPVTPWPTAYSEIYDYQWNEKLIPY
WQDLAEFAKEQDVKIAIELHAGFLVHTPYTMLKLREATNEYIGANLDPSH
LWWQGIDPIAAIRILGQANAIHHFHAKDTYINQENVNMYGLTDMQPYGNV
ATRAWTFRTVGYGHSPYVWADIISQLIINGYDYVLSIEHEDPIMSVEEGF
QKACQTLKSVNIYDKPADMWWA
>SAUSA300_0194 sucrose-specific PTS tranporter protein
MTKEQQLAERIIAAVGGMDNIDSVMNCMTRVRIKVLDENKVDDQELRHID
GVMGVIHDERIQVVVGPGTVNKVANHMAELSGVKLGDPIPHHHNDSEKMD
YKSYAADKAKANKEAHKAKQKNGKLNKVLKSIANIFIPLIPAFIGAGLIG
GIAAVLSNLMVAGYISGAWITQLITVFNVIKDGMLAYLAIFTGINAAKEF
GATPGLGGVIGGTTLLTGIAGKNILMNVFTGEPLQPGQGGIIGVIFAVWI
LSIVEKRLHKIVPNAIDIIVTPTIALLIVGLLTIFIFMPLAGFVSDSLVS
VVNGIISIGGVFSGFIIGASFLPLVMLGLHHIFTPIHIEMINQSGATYLL
PIAAMAGAGQVGAALALWVRCKRNTTLRNTLKGALPVGFLGIGEPLIYGV
TLPLGRPFLTACIGGGIGGAVIGGIGHIGAKAIGPSGVSLLPLISDNMYL
GYIAGLLAAYAGGFVCTYLFGTTKAMRQTDLLGD
>SAUSA300_0260 bglA, 6-phospho-beta-glucosidase
MTKLPQNFMWGGALAANQFEGGYDKGGKGLSVIDVMTSGAHGKARQITES
IDPNHYYPNHEGIDFYHRYKEDIALFKEMGLKCLRTSIAWTRIFPNGDED
VPNEEGLAFYDRIFDELIAQGIEPVVTLSHFEMPLHLAKHYGGFRNREVV
DYFVHFARVVFERYKDKVTYWMTFNEINNQMDTSNPIFLWTNSGVALTEN
DNPEEVLYQVAHHELLASALAVRLGKEINPKFKIGTMISHVPIYPYSCHP
KDMMEAQIANRLRFFFPDVQVRGYYPSYAKKMLARKGYDVGWQEGDDSIL
QQGTVDYIGFSYYMSTAVKHDVDTTVENNIVNGGLNHSVENPHIATSDWG
WAIDPDGLRYTLNVLYDRYQLPLFIVENGFGAVDEVVDGHIHDDYRIEYL
KAHITAAIEAVDQDGVDLIGYTPWGIIDIVSFTTGEMKKRYGLIYVDRDN
DGHGTMERLKKDSFYWYQQVIASNGDKL
>SAUSA300_2596 cap1C, capsular polysaccharide biosynthesis protein Cap1C
MIDIHNHILVDIDDGPKTIEKSIALLKQAKDEGVTSIVATPHHLHPRYDN
TFQQVLVKLAELRTHPEVQALDIKLFPGQEIRITDSILKGLDNGSIQGIN
RSKYLLIEFPTGEVPHYTKQLFFEIQSRGYIPIIAHPERNRSIAKNPEIL
YELVANGALSQLTSSSLVGGFGKNIQKLSLQFIECNLAHFVASDAHSCDQ
RPFLMQELFHNHKLKKYSNDIEALLRNASSVINDNFVYLDRPTKPGKVKS
FLKWF
>SAUSA300_0154 cap5C, capsular polysaccharide biosynthesis protein Cap5C
MIDIHNHILPNIDDGPTNETEMMDLLKQATTQGVTEIIVTSHHLHPRYTT
PIEKVKSCLNHIESLEEVQALNLKFYYGQEIRITDQILNDIDRKVINGIN
DSRYLLIEFPSNEVPHYTDQLFFELQSKGFVPIIAHPERNKAISQNLDIL
YDLINKGALSQVTTASLAGISGKKIRKLAIQMIENNLTHFIGSDAHNTEI
RPFLMKDLFNDKKLRDYYEDMNGFISNAKLVVDDKKIPKRMPQQDYKQKR
WFGL
>SAUSA300_0156 cap5E, capsular polysaccharide biosynthesis protein Cap5E
MFDDKILLITGGTGSFGNAVMKQFLDSNIKEIRIFSRDEKKQDDIRKKYN
NSKLKFYIGDVRDSQSVETAMRDVYYVFHAAALKQVPSCEFFPVEAVKTN
IIGTENVLQSAIHQNVKKVICLSTDKAAYPINAMGISKAMMEKVFVAKSR
NIRSEQTLICGTRYGNVMASRGSVIPLFIDKIKAGEPLTITDPDMTRFLM
SLEDAVELVVHAFKHAETGDIMVQKAPSSTVGDLATALLELFEADNAIEI
IGTRHGEKKAETLLTREEYAQCEDMGDYFRVPADSRDLNYSNYVETGNEK
ITQSYEYNSDNTHILTVEEIKEKLLTLEYVRNELNDYKASMR
>SAUSA300_0165 cap5N, capsular polysaccharide biosynthesis protein Cap5N
MRKNILITGVHGYIGNALKDKLIEQGHQVDQINVRNQLWKSTSFKDYDVL
IHTAALVHNNSPQARLSDYMQVNMLLTKQLAQKAKAEDVKQFIFMSTMAV
YGKEGHVGKSDQVDTQTPMNPTTNYGISKKFAEQALQELISDSFKVAIVR
PPMIYGAHCPGNFQRLMQLSKRLPIIPNINNQRSALYIKHLTAFIDQLIS
LEVTGVYHPQDSFYFDTSSVMYEIRRQSHRKTVLINMPSMLNKYFNKLSV
FRKLFGNLIYSNTLYENNNALEIIPGKMSLVIADIMDETTTKDKA
>SAUSA300_1315 crr, PTS system, glucose-specific IIA component
MFKKLFGKGKEVQKDIAIYAPLTGEFVKIEDIPDPVFAQKMMGEGFGINP
TEGEVVSPIAGRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFE
VLVSSGDEVNVGDPLVRFNLEYINNNAKSVISPIIITNTDQAASINIYDE
NAVIKGETKVIDVTMN
>SAUSA300_0141 deoB, phosphopentomutase
MTRPFNRVHLIVMDSVGIGEAPDAADFKDEGSHTLRHTLEGFDQTLPNLE
KLGLGNIDKLPVVNAVEQPEAYYTKLSEASVGKDTMTGHWEIMGLNIMQP
FKVYPNGFPEELIQQIEEMTGRKVVANKPASGTQIIDEWGEHQMKTGDLI
VYTSADPVLQIAAHEDIIPLEELYDICEKVRELTKDPKYLIGRIIARPYV
GEPGNFTRTSNRHDYALKPFGKTVLDHLKDGGYDVIAIGKINDIYDGEGV
TEAVRTKSNMDGMDQLMKIVKKDFTGISFLNLVDFDALYGHRRDKPGYAQ
AIKDFDDRLPELFSNLKEDDLVIITADHGNDPTAPGTDHTREYIPVIMYS
PKFKGGHALESDTTFSSIGATIADNFNVTLPEFGKSYLKELK
>SAUSA300_0760 eno, phosphopyruvate hydratase
MPIITDVYAREVLDSRGNPTVEVEVLTESGAFGRALVPSGASTGEHEAVE
LRDGDKSRYLGKGVTKAVENVNEIIAPEIIEGEFSVLDQVSIDKMMIALD
GTPNKGKLGANAILGVSIAVARAAADLLGQPLYKYLGGFNGKQLPVPMMN
IVNGGSHSDAPIAFQEFMILPVGATTFKESLRWGTEIFHNLKSILSKRGL
ETAVGDEGGFAPKFEGTEDAVETIIQAIEAAGYKPGEEVFLGFDCASSEF
YENGVYDYSKFEGEHGAKRTAAEQVDYLEQLVDKYPIITIEDGMDENDWD
GWKQLTERIGDRVQLVGDDLFVTNTEILAKGIENGIGNSILIKVNQIGTL
TETFDAIEMAQKAGYTAVVSHRSGETEDTTIADIAVATNAGQIKTGSLSR
TDRIAKYNQLLRIEDELFETAKYDGIKSFYNLDK
>SAUSA300_2079 fba, fructose bisphosphate aldolase
MPLVSMKEMLIDAKENGYAVGQYNINNLEFTQAILEASQEENAPVILGVS
EGAARYMSGFYTIVKMVEGLMHDLNITIPVAIHLDHGSSFEKCKEAIDAG
FTSVMIDASHSPFEENVATTKKVVEYAHEKGVSVEAELGTVGGQEDDVVA
DGIIYADPKECQELVEKTGIDALAPALGSVHGPYKGEPKLGFKEMEEIGL
STGLPLVLHGGTGIPTKDIQKAIPFGTAKINVNTENQIASAKAVRDVLNN
DKEVYDPRKYLGPAREAIKETVKGKIKEFGTSNRAK
>SAUSA300_0685 fruA, fructose specific permease
MRVTELLTKDTIAMDLMANDKNGVIDELVNQLDKAGKLSDVASFKEAIHN
RESQSTTGIGEGIAIPHAKVAAVKSPAIAFGKSKAGVDYQSLDMQPAHLF
FMIAAPEGGAQTHLDALAKLSGILMDENVREKLLHASSPEEVLAIIDEAD
DEVTKEEEAEAEAQQVATAEQSSKQSNEPYVLAVTACPTGIAHTYMARDA
LKKQADKMGIKIKVETNGSSGIKNHLTEQDIENATGIIVAADVHVETDRF
DGKNVVEVPVADGIKRPEELINKALDTSRKPFVARDGQRKGNSNDSQEKL
SPGKAFYKHLMNGVSNMLPLVISGGILMAIVFLFGANSFNPKSSEYNAFA
EQLWNIGSKSAFALIIPILSGFIARSIADKPGFASGLVGGMLAISGGSGF
IGGIIAGFLAGYLTQGVKAMTRKLPQALEGLKPTLIYPLLTVTATGLLMI
YAFNPPASWLNHLLLDGLNNLSGSNIVLLGLVIGAMMAIDMGGPFNKAAY
VFATGALIEGNAAPITAAMIGGMIPPLAIATAMLIFRRKFTKEQRGSIIP
NYVMGMSFITEGAIPFAAADPLRVIPSMMIGSGIGGAIALGLGSRITAPH
GGIIVIVGTDGAHLLQTLIALLVGTLVSALIYGLIKPKLTETEIEASKSM
DE
>SAUSA300_0684 fruB, fructose 1-phosphate kinase
MIYTVTFNPSIDYVIFTNDFKIDGLNRATATYKFAGGKGINVSRVLKTLD
VESTALGFAGGFPGKFIIDTLNNSAIQSNFIEVDEDTRINVKLKTGQETE
INAPGPHITSTQFEQLLQQIKNTTSEDIVIVAGSVPSSIPSDAYAQIAQI
TAQTGAKLVVDAEKELAESVLPYHPLFIKPNKDELEVMFNTTVNSDTDVI
KYGRLLVDKGAQSVIVSLGGDGAIYIDKEISIKAVNPQGKVVNTVGSGDS
TVAGMVAGIASGLTIEKAFQQAVACGTATAFDEDLATRDAIEKIKSQVTI
SVLDGE
>SAUSA300_2285 galM, aldose 1-epimerase
MIVEVEHQRQGVDLIKIDNDETKIIFTNYGARVVSWKYHDNNIVLGNVVE
ADEFYHSNPFKFGASIGRYSGRIDNAKFKLKGKEYQLEKNNGEHHLHGGC
HGLDNKLFDYEIRNEIAQIKVIFKTVLKSADDHFPGDIDVTITHIYDADH
QWSIEYEAVASEDTLFSPTNHVYFNLNRDNNVVDNHRISSNQLDMYVLDE
RNIVTGDILDLHEVFEDNKIKLSDIFTSQHAQLSQQMTRFGGLDHPFTVG
EHKMYVENHEFMLEVDTDMPHVVFFTFNQPDEWDSPFNIYKPHSGFTLET
QFLPNDINLYGEKAPSILKAGEVFNSKTSFRIEEKVEND
>SAUSA300_1633 gap, glyceraldehyde-3-phosphate dehydrogenase, type I
MSTNIAINGMGRIGRMVLRIALQNKNLNVVAINASYPPETIAHLINYDTT
HGKYNLKVEPIENGLQVGDHKIKLVADRNPENLPWKELDIDIAIDATGKF
NHGDKAIAHIKAGAKKVLLTGPSKGGHVQMVVKGVNDNQLDIEAFDIFSN
ASCTTNCIGPVAKVLNNQFGIVNGLMTTVHAITNDQKNIDNPHKDLRRAR
SCNESIIPTSTGAAKALKEVLPELEGKLHGMALRVPTKNVSLVDLVVDLE
KEVTAEEVNQAFENAGLEGIIEVEHQPLVSVDFNTNPNSAIIDAKSTMVM
SGNKVKVIAWYDNEWGYSNRVVDVAEQIGALLTSKETVSAS
>SAUSA300_0756 gap, glyceraldehyde-3-phosphate dehydrogenase, type I
MAVKVAINGFGRIGRLAFRRIQEVEGLEVVAVNDLTDDDMLAHLLKYDTM
QGRFTGEVEVVDGGFRVNGKEVKSFSEPDASKLPWKDLNIDVVLECTGFY
TDKDKAQAHIEAGAKKVLISAPATGDLKTIVFNTNHQELDGSETVVSGAS
CTTNSLAPVAKVLNDDFGLVEGLMTTIHAYTGDQNTQDAPHRKGDKRRAR
AAAENIIPNSTGAAKAIGKVIPEIDGKLDGGAQRVPVATGSLTELTVVLE
KQDVTVEQVNEAMKNASNESFGYTEDEIVSSDVVGMTYGSLFDATQTRVM
SVGDRQLVKVAAWYDNEMSYTAQLVRTLAYLAELSK
>SAUSA300_2210 glcU, probable glucose uptake protein
MQFLDFLIALLPALFWGSVVLINVFVGGGPYNQIRGTTLGALIVGLGLLI
TGFAKFNNPTVIIVGLISGALWAFGQANQLKSISLIGVSNTMPVSTGMQL
VGTTLFSVIFLGEWSSMTQIIFGLIAMILLVTGVALTSLKAKNERQSDNP
EFKKAMGILIVSTVGYVGFVVLGDIFGVGGTDALFFQSVGMAIGGFILSM
NHKTSLKSTALNLLPGVIWGIGNLFMFYSQPKVGVATSFSLSQLLVIVST
LGGIFILGERKDRRQMTGIWAGIIIIVIAAIILGNLK
>SAUSA300_1507 glk, glucokinase
MTKIILAADVGGTTCKLGIFTPELEQLHKWSIHTDTSDSTGYTLLKGIYD
SFVEKVNENNYNFSNVLGVGIGVPGPVDFEKGTVNGAVNLYWPEKVNVRE
IFEQFVDCPVYVDNDANIAALGEKHKGAGEGADDVVAITLGTGLGGGIIS
NGEIVHGHNGSGAEIGHFRADFDQRFKCNCGRSGCIETVASATGVVNLVN
FYYPKLTFRSSILELIKENKVTAKAVFDAAKAGDQFCIFITEKVANYIGY
LCSIISVTSNPKYIVLGGGMSTAGPILIENIKTEYHNLTFAPAQFETEIV
QAKLGNDAGITGAAGLIKTYVLDKEGVK
>SAUSA300_2111 glmM, phosphoglucosamine mutase
MGKYFGTDGVRGVANQELTPELAFKLGRYGGYVLAHNKGEKHPRVLVGRD
TRVSGEMLESALIAGLISIGAEVMRLGIISTPGVAYLTRDMGAELGVMIS
ASHNPVADNGIKFFGSDGFKLSDEQENEIEALLDQENPELPRPVGNDIVH
YSDYFEGAQKYLSYLKSTVDVNFEGLKIALDGANGSTSSLAPFLFGDLEA
DTETIGCSPDGYNINEKCGSTHPEKLAEKVVETESDFGLAFDGDGDRIIA
VDENGQIVDGDQIMFIIGQEMHKNQELNNDMIVSTVMSNLGFYKALEQEG
IKSNKTKVGDRYVVEEMRRGNYNLGGEQSGHIVMMDYNTTGDGLLTGIQL
ASVIKMTGKSLSELAGQMKKYPQSLINVRVTDKYRVEENVDVKEVMTKVE
VEMNGEGRILVRPSGTEPLVRVMVEAATDEDAERFAQQIADVVQDKMGLD
K
>SAUSA300_1191 glpF, glycerol uptake facilitator
MNVYLAEFLGTAILILFGGGVCANVNLKRSAANGADWIVITAGWGLAVTM
GVFAVGQFSGAHLNPAVSLALALDGSFDWSLVPGYIVAQMLGAIVGATIV
WLMYLPHWKATEEAGAKLGVFSTAPAIKNYFANFLSEIIGTMALTLGILF
IGVNKIADGLNPLIVGALIVAIGLSLGGATGYAINPARDLGPRIAHAILP
IAGKGGSNWSYAIVPILGPIAGGLLGAVVYAVFYKHTFNIGCAIAIVVVI
ITLILGYILNKSSKKGDIESIY
>SAUSA300_0337 glpT, glycerol-3-phosphate transporter
MNFLKPAKHIKPLPENQIDDTYKRLRLQVFLGIFIGYAGYYLLRKNFSLA
MPALQEQGFTKAELGFALSAVSIAYGFSKFFMGTVSDRSNARIFLVLGLA
LTAIVNLLMGFVPFFTSGIGIMFVLLFLNGWFQGMGWPPSGRVLVHWFSV
SERGSKTALWNVAHNVGGGIMAPIAAWGITTTAFINFGYLKGFEGVFIYP
ALLALIIAAISYVLIRDTPQSQGLPPIEIYKNDFATSDKKTLETELTTKE
ILFKYVLNNKWVWAIAFANIFVYFVRYGVLDWAPVYLSEEKHFDLKASGW
AYFLYEWAGIPGTLLCGYISDKLFKGRRGPAGFFFMLGVTVFVLIYWLNP
PGNAWLDNVSLIAIGFLIYGPVMLIGLQALDYVPKKAAGTAAGLTGLFGY
LFGAVMANIVLGAVVDKFGWDVGFILLTAISVFAMLSFILTWNKVGQETV
HH
>SAUSA300_2270 glvC, PTS system, arbutin-like IIBC component
MNAIKRFGSAMIVPVLMFAFFGIVLGFATLFKNPTIMGSLADQHTFWFKF
WSVIESGGWVIFTHMEVVFVVGLPLSLAKKAPGHAALAALMGYLMFNTFI
NAILTQWPHTFGANLEKGVENVPGLKSIAGIATLDTNILGGIIISAIITW
IHNRYYSKRLPEMVGVFQGLTFVVTISFFVMLPLAAITCVIWPTVQHGIG
SMQHFIIASGYIGVWLYHFLERVLIPTGLHHFIYAPIEVGPVVVNHGLKA
EWLQHLNEFAKSTKPLKEQFPYGFMLQGNGKVFGCLGIALAMYATTPKEN
RKKVAALLIPATLTAVVVGITEPLEFTFLFIAPYLFVLHAVLAASMDTLM
YAFGVVGNMGGGLLDFISTNWLPLGKEHWGTYVAQVIIGLIFVAIYFFLF
RFLILKFDIPLPGRKKTEEEVKLFSKQDYKNKKGDSVDSKRASSGNEYED
KAAYYLDGLGGKENIKDVTNCTTRLRLTVYDESKVADTEYFTHQQMAHGL
VKSGKSIQVVVGMTVPQVREAFEQMVEDQSSEDK
>SAUSA300_1459 gnd, 6-phosphogluconate dehydrogenase, decarboxylating
MTQQIGVIGLAVMGKNLAWNIESRGYSVSVFNRSSEKTDLMVEESKGKNI
HPTYSLEEFVNSLEKPRKILLMVQAGKATDATIDSLLPLLDDGDILIDGG
NTNYQDTIRRNKALAQSAINFIGMGVSGGEIGALTGPSLMPGGQEEAYNK
VADILDAIAAKAKDGASCVTYIGPNGAGHYVKMVHNGIEYADMQLIAESY
AMMKELLGMSHEDIAQTFKDWNAGELESYLIEITGDIFMKLDENKEALVE
KILDTAGQKGTGKWTSINALELGIPLTIITESVFARFISSIKEERVNASK
ELNGPKASFDGDKKDFLEKIRKALYMSKICSYAQGFAQMRKASEDNEWNL
KLGDLAMIWREGCIIRAQFLQKIKDAYDNNPGLQNLLLDPYFKNIVTEYQ
DALRDVVATGVQNGVPTPGFSSSINYYDSYRAADLPANLIQAQRDYFGAH
TYERKDKEGVFHTQWIEE
>SAUSA300_2443 gntK, gluconate kinase
MKYMIGVDIGTTSTKSVLYDENGTFIMKHQIGYDLHTPNVDVSEENPDEL
FDAVLMTIKYVMRESKVNKDDIKFVSFSAQMHSLIAMDQQHQRLTNNITW
ADNRAAKYATVINEVHDGNAIYQRTGTPIHPMSPLAKIFWMKHEWQDVFQ
RTAKFADIKTYIFYHLFDTYIIDYSMASATGMFNLETLDWDVEALELLGI
SKEMLPELVPTTYVMKGMKERYATLMGLNKDTPFVIGASDGVLSNLGVNS
VGKGEVAVTIGTSGAIRTVIDKPRTDYKGRIFCYVLTEDHYVIGGPVNNG
GVVLRWLRDELLASEVETAKRLGVDPYDVLTQIAKRVKPGADGLIFHPYL
AGERAPLWNANARGSFFGLTLSHKKEHMIRAALEGVLYNLYTVYLALIEV
MNETPKMIKATGGFAKSEVWRQMMSDIFDTELVVPESYESSCLGACVLGL
KAVGDIEDFSIVSSMVGATNNHTPIEENVTVYQEIVSIFINLSRSLTENY
EQIADFQRQHIAENKTQ
>SAUSA300_2442 gntP, gluconate permease
MFNEIWPLISVVLGIVILLVLIIGFKLNTFISLIITSMITALMLGIPLTK
IMETIEKGMGSTLGHIALIFGLGAILGKLLADGGGATRIADTLIQKFGQK
HVQWAMLVAAFIVGIALFFEVGLVLLIPLVFTVAKRANVSVLKLGLPMVT
ALSVTHGFLPPHPGPVVIAKELKANVGDVLLYGMIIAIPVTLIAGPIFNK
VAQKMIPSAYTREGDISALGAQKEFTDQEMPGFGMSLLTATLPVILMLVS
TITQLVTGHDKPTNLFESIIYMIGTAGTAMLIAVLFAIVTMGLMRKRKMN
HIMESVTNAIYPIGMMLLIIGGGGTFKQVLIDGGVGNTIAKMFEGTEMSP
ILLAWIVAAVLRIALGSATVAAISTTGIVLPLLQSSDVNVALVVLAIGAG
SVILSHVNDAGFWMFKEYFGLTVKETFLTWSLLETIISVSGIIFILFISL
FV
>SAUSA300_2362 gpmA, 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MPKLILCRHGQSEWNAKNLFTGWEDVNLSEQGINEATRAGEKVRENNIAI
DVAFTSLLTRALDTTHYILTESKQQWIPVYKSWRLNERHYGGLQGLNKDD
ARKEFGEEQVHIWRRSYDVKPPAETEEQREAYLADRRYNHLDKRMMPYSE
SLKDTLVRVIPFWTDHISQYLLDGQTVLVSAHGNSIRALIKYLEDVSDED
IINYEIKTGAPLVYELTDDLEVIDKYYL
>SAUSA300_0759 gpmI, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MAKKPTALIILDGFANRESEHGNAVKLANKPNFDRYYNKYPTTQIEASGL
DVGLPEGQMGNSEVGHMNIGAGRIVYQSLTRINKSIEDGDFFENDVLNNA
IAHVNSHDSALHIFGLLSDGGVHSHYKHLFALLELAKKQGVEKVYVHAFL
DGRDVDQKSALKYIEETEAKFNELGIGQFASVSGRYYAMDRDKRWEREEK
AYNAIRNFDAPTYATAKEGVEASYNEGLTDEFVVPFIVENQNDGVNDGDA
VIFYNFRPDRAAQLSEIFANRAFEGFKVEQVKDLFYATFTKYNDNIDAAI
VFEKVDLNNTIGEIAQNNNLTQLRIAETEKYPHVTYFMSGGRNEEFKGER
RRLIDSPKVATYDLKPEMSAYEVKDALLEELNKGDLDLIILNFANPDMVG
HSGMLEPTIKAIEAVDECLGEVVDKILDMDGYAIITADHGNSDQVLTDDD
QPMTTHTTNPVPVIVTKEGVTLRETGRLGDLAPTLLDLLNVEQPEDMTGE
SLIKH
>SAUSA300_2601 icaB, intercellular adhesion protein B
MKYRKFIILVLSILIILPVSTLDGHHIANADDDSPKKLKYKENSALALNY
HRVRKANFLNNFIYFFSSSKEIKNYSVSQSQFESQIKWLKSHDAKFLTLK
EFLYYKKKGKFPKRSVWINFDDMDETIYENAYPILKKYKIPATGFIITGH
VGEENFHNLDMISKKELKEMYKTGLWEFETHTHDLHNLSKNNKSKLMKAS
EATIIKDLNKSEKYLTKNFKKSQKTIAYPYGLMNDDKLPVIKKAGLKYGF
SLEEKAVTPNSNDYYIPRILISDDAFEHLIKRWDGFHEKD
>SAUSA300_2602 icaC, intercellular adhesion protein C
MKKIRLELVYLRAIICAIIIITHLLTQITLKHENMEGGSLVLQFYIRNIV
IFGTPCFIILSQLLTTLNYQKVTYRYLTTRVKYILIPYILMGLFYSYSES
LLTDSSFNKQFIENVLLGQWYGYFIVVIMQFFILSYIIFKINYNLFNSKI
LLLLSFILQQSFLYYFTNNTAFHDTVLHYYPLSENTIIFGWIFYFFLGAY
MGYNYERVLNFLERYLVIMIVLAVATYFVFIALANGDYWNVTSFSYSLTP
YNSIMFIVILGICTHFKTMLFNTIQMISAFSFFIYLLHPIILDSLFAYTN
IFEDNTMVFLAISLLFILGLCIGVGMILREFYIFRFIIGKQPYKLNINAY
>SAUSA300_2006 ilvD, dihydroxy-acid dehydratase
MRSDMIKKGDHQAPARSLLHATGALKSPTDMNKPFVAICNSYIDIVPGHV
HLRELADIAKEAIREAGAIPFEFNTIGVDDGIAMGHIGMRYSLPSREIIA
DAAETVINAHWFDGVFYIPNCDKITPGMILAAMRTNVPAIFCSGGPMKAG
LSAHGKALTLSSMFEAVGAFKEGSISKEEFLDMEQNACPTCGSCAGMFTA
NSMNCLMEVLGLTLPYNGTALAVSDQRREMIRQAAFKLVENIKNDLKPRD
IVTREAIDDAFALDMAMGGSTNTVLHTLAIANEAGIDYDLERINAIAKRT
PYLSKIAPSSSYSMHDVHEAGGVPAIINELMKKDGTLHPDRITVTGKTLR
ENNEGKEIKNFDVIHPLDAPYDAQGGLSILFGNIAPKGAVIKVGGVDPSI
KTFTGKAICFNSHDEAVEAIDNRTVRAGHVVVIRYEGPKGGPGMPEMLAP
TSSIVGRGLGKDVALITDGRFSGATRGIAVGHISPEAASGGPIALIEDGD
EITIDLTNRTLNVNQPEDVLARRRESLTPFKAKVKTGYLARYTALVTSAN
TGGVMQVPENLI
>SAUSA300_0190 ipdC, indole-3-pyruvate decarboxylase
MKQRIGAYLIDAIHRAGVDKIFGVPGDFNLAFLDDIISNPNVDWVGNTNE
LNASYAADGYARLNGLAALVTTFGVGELSAVNGIAGSYAERIPVIAITGA
PTRAVEQGGKYVHHSLGEGTFDDYRKMFAHITVAQGYITPENATTEIPRL
INTAIAERRPVHLHLPIDVAISEIEIPTPFEVTATKYTDASTYIELLATK
LHQAKQPIIITGHEINSFHLHQELEDFVNQTQIPVAQLSLGKGAFNEENP
YYMGIYDGKIAEDKIRDYVDNSDLILNIGAKLTDSATAGFSYQFNIDDVV
MLNHHNIKIDDVTNDEISLPSLLKQLSNISYTNNATFPAYHRPTSPDYTV
GTEPLTQQTYFKMMQNFLKPNDVIIADQGTSFFGAYDLALYKNNTFIGQP
LWGSIGYTLPATLGSQLADKDRRNLLLIGDGSLQLTVQAISTMIRQHIKP
VLFVINNDGYTVERLIHGMYEPYNEIHMWDYKALPAVFGGKNVEIHDVES
SKDLQDTFNAINGHPDVMHFVEVKMAVEDAPKKLIDIAKAFSQQNK
>SAUSA300_2155 lacA, galactose-6-phosphate isomerase
MAIIIGSDEAGKRLKEVIKSYLLDNKYDVVDVTEGQEVDFVDATLAVAKD
VQSQEGNLGIVIDAFGAGSFMVATKIKGMIAAEVSDERSGYMTRGHNNSR
MITMGSEIVGDTLAKNVVKGFVEGKYDGGRHQIRVDMLNKMC
>SAUSA300_2154 lacB, galactose-6-phosphate isomerase
MKIALGCDHIVTDTKMRVSEFLKSKGHEVIDVGTYDFTRTHYPIFGKKVG
EQVVSGNADLGVCICGTGVGINNAVNKVPGVRSALVRDMTSALYAKEELN
ANVIGFGGRIIGELLMCDIIDAFINAEYKPTEENKKLIAKIKHLETSNAD
QADPHFFDEFLEKWDRGEYHD
>SAUSA300_2153 lacC, tagatose-6-phosphate kinase
MILTLTLNPSVDISYPLTALKLDDVNRVQEVSKTAGGKGLNVTRVLAQVG
EPVLASGFIGGELGQFIAKKLDHADIKHAFYNIKGETRNCIAILHEGQQT
EILEQGPEIDNQEAAGFIKHFEQLLEKVEAVAISGSLPKGLNQDYYAQII
ERCQNKGVPVILDCSGATLQTVLENPYKPTVIKPNISELYQLLNQPLDES
LESLKQAVSQPLFEGIEWIIVSLGAQGAFAKHNHTFYRVNIPTISVLNPV
GSGDSTVAGITSAILNHENDHDLLKKANTLGMLNAQEAQTGYVNLNNYDD
LFNQIEVLEV
>SAUSA300_2152 lacD, tagatose 1,6-diphosphate aldolase
MSKSNQKIASIEQLSNNEGIISALAFDQRGALKRMMAKHQTEEPTVAQIE
QLKVLVAEELTQYASSILLDPEYGLPASDARNKDCGLLLAYEKTGYDVNA
KGRLPDCLVEWSAKRLKEQGANAVKFLLYYDVDDAEEINIQKKAYIERIG
SECVAEDIPFFLEVLTYDDNIPDNGSVEFAKVKPRKVNEAMKLFSEPRFN
VDVLKVEVPVNMKYVEGFAEGEVVYTKEEAAQHFKDQDAATHLPYIYLSA
GVSAELFQETLKFAHEAGAKFNGVLCGRATWSGAVQVYIEQGEDAAREWL
RTTGFKNIDDLNKVLKDTATSWKQRK
>SAUSA300_2150 lacE, PTS system, lactose-specific IIBC component
MMQKLIAQIEKGKPFFEKLSRNIYLRAIRDGFISAMPVILFSSIFLLIAY
VPNIFGFKWDKGMEAILMKPYNYTMGLVAFLVAGTTAKSLTDSFNRKLES
TNQINFISTMLAAMCGFLFLASDPAKDGGFLSAFMGTKGLLTAFLSAFVT
VIVYNFCVKRNITIKMPKEVPPNISQVFKDLIPFSAVIIILYALDLVIRN
SFKSNVAEGILKLFEPLFTAADGWIGVTIIFGAFALFWFVGIHGPSIVEP
AIAAITYANIEANFKLLQAGEHADKIITSGTQMFIVTFGGTGATLVVPFM
FMWMTKSKRNKAIGRASVVPTFFGVNEPILFGAPLVLNPVFFIPFVLAPI
VNVWIFKLFVEVLGMNSFSVNLPWTTPGPLGIIMGTGFGLWSFVLAITLI
VVDIIIYYPFLKVYDSEILDEEEGRKESNSDLKEKVAANFDTKKADSILA
ASGVSDDAAKASNITEQTNVLVLCAGGGTSGLLANALNKAAEEYHVPVKA
AAGGYGAHMDIMKEYQLIILAPQVASNYEDIKQDTDRLGIKLAKTQGAEY
IKLTRDGQAALDFVQQQFEN
>SAUSA300_2151 lacF, PTS system, lactose-specific IIA component
MNREEVQLLGFEIVAFAGDARSKFLEALTAAQAGDFAKADALIEEGNNCI
AEAHRAQTSLLAKEAQGDDIAYSVTMMHGQDHLMTTILLKDLMKHLLEFY
KRG
>SAUSA300_2149 lacG, 6-phospho-beta-galactosidase
MTKTLPEDFIFGGATAAYQAEGATNTDGKGRVAWDTYLEENYWYTAEPAS
DFYNRYPVDLELSEKFGVNGIRISIAWSRIFPNGYGEVNPKGVEYYHKLF
AECHKRHVEPFVTLHHFDTPEVLHKDGDFLNRKTIDYFVDYAEYCFKEFP
EVKYWTTFNEIGPIGDGQYLVGKFPPGIKYDFEKVFQSHHNMMVAHARAV
KLFKDGGYKGEIGVVHALPTKYPFDPSNPEDVRAAELEDIIHNKFILDAT
YLGKYSRETMEGVQHILSVNGGKLNITDEDYAILDAAKDLNDFLGINYYM
SDWMRGYDGESEITHNATGDKGGSKYQLKGVGQREFDVDVPRTDWDWMIY
PQGLYDQIMRVVKDYPNYHKIYITENGLGYKDEFIESEKTVHDDARIDYV
RQHLNVIADAIIDGANVKGYFIWSLMDVFSWSNGYEKRYGLFYVDFETQE
RYPKKSAYWYKELAETKEIK
>SAUSA300_2577 manA, mannose-6-phosphate isomerase, class I
MALFLQPVFKDRIWGGHALKAFNYDIPNETTGECWAISAHPNGPNTIING
PYKDMTLDQLWSQHRELFDNDSRDSFPLLTKVLDANDKLSVQVHPDDDYA
LKHEGELGKTECWYILDAAPGAEIIYGVHAHNKQTLIDMIDNHEFDSLFK
RIPVKPGDFYYVPAGTVHAIGSGILILETQQSSDTTYRIYDYDRRDQNGQ
LRDLHLEQSKDVIELGNHEPNTTPITTHIDTHTVTQFVDNQYFAVYKWDI
HGDLKFNKPHAYCLVTIIDGTGTLTVNDKHYDIQKGSSFILTTEDEDIHF
VGNISAIVSHPG
>SAUSA300_2096 manA, mannose-6-phosphate isomerase
MPLFLQPILKTKLWGGQRLSEFGYQLDNDTTGECWCVSAHPNGTSEIING
PYQGQTLDRIWSEHRELFGDFPSKDFPLLTKIVDARESLSIHVHPDNSYA
YEHENGQYGKSECWYIIDAEEDAEIVIGTLAESREEVANHVQHGTIESIL
RYIKVKPGEFYFIPAGTVHTISSGILAYETMQSSDITYRLYDFNRQDNQY
NDRPLNIEKALDVIQYNAPLPNILPESEIIENHKCTHIVSNDFFTLVKWE
ISGTLNYMKPREFCLVTVLEGEGQMIVDGEIFKLTTGTNFILTSEDLDSV
FEGDFTLMISYV
>SAUSA300_2107 mtlA, PTS system, mannitol specific IIA component
MSELFSNDNIFLNVNVNSQNEAIEKAGKALVDSGAVTDAYIQAMKDREQV
VSTFMENGLAIPHGTDEAKTNVIHSGLTLLQIPEGVDWDGEVVKVVVGIA
GKDGEHLDLLSKIAITFSEEENVDRIVQAKSAEEIKQVFEEADA
>SAUSA300_2108 mtlD, Mannitol-1-phosphate 5-dehydrogenase
MKAVHFGAGNIGRGFIGYILADNNVKVTFADVNEEIINALAHDHQYDVIL
ADESKTTTRVNNVDAINSMQPSEALKQAILEADIITTAVGVNILPIIAKS
FAPFLKEKTNHVNIVACENAIMATDTLKKAVLDITGPLGNNIHFANSAVD
RIVPLQKNENILDVMVEPFYEWVVEKDAWYGPELNHIKYVDDLTPYIERK
LLTVNTGHAYLAYAGKFAGKATVLDAVEDSSIEAGLRRVLAETSQYITNE
FDFTEAEQAAYVEKIIDRFNNSYLSDEVTRVGRGTLRKIGPKDRIIKPLT
YLYNKDLERTGLLNTAALLLKYDDTADQETVEKNNYIKEHGLKAFLSEYA
KVDDGLADEIIEAYNSLS
>SAUSA300_2105 mtlF, PTS system, mannitol specific IIBC component
MSQTEEKKGIGRRVQAFGSFLSSMIMPNIGAFIAWGFIAAIFIDNGWLPN
KDLATLAGPMITYLIPLLIAFSGGRLIYDLRGGIIAATATMGVIVALPDT
PMLLGAMIMGPLVGWLMKKTDQLIQPRTPQGFEMLFNNFSAGILGFIMTI
AGFKILAPLMKFIMHILSVAVEALVHAHLLPLVSILVEPAKIVFLNNAIN
HGVFTPLGADQAAKAGQSILYTIESNPGPGLGILLAYMIFGKGTAKATSY
GAGIIHFLGGIHEIYFPYVLMRPLLFIAVILGGMTGVATYQATGFGFKSP
ASPGSFIVYCLNAPRGEFLHMLLGVFLAALVSFVVAALIMKFTREPKQDL
EAATAQMENTKGKKSSVASKLVSSDKNVNTEENASGNVSETSSSDDDPEA
LLDNYNTEDVDAHNYNNINHVIFACDAGMGSSAMGASMLRNKFKKAGIND
ITVTNTAINQLPKDAQLVITQKKLTDRAIKQTPNAIHISVDNFLNSPRYE
ELLNNLKKDDQA
>SAUSA300_0686 nagA, N-acetylglucosamine-6-phosphate deacetylase
MSELIIYNGKVYTEDGKIDNGYIHVKDGQIVAIGEVDDKAAIDNDTTNKI
QVIDAKGHHVLPGFIDIHIHGGYGQDAMDGSYDGLKYLSENLLSEGTTSY
LATTMTQSTDKIDNALTNIAKYEAEQDVHNAAEIVGIHLEGPFISENKVG
AQHPQYVVRPFIDKIKHFQETANGLIKIMTFAPEVEGAKEALETYKDDII
FSIGHTVATYEEAVEAVERGAKHVTHLYNAATPFQHREPGVFGAAWLNDA
LHTEMIVDGTHSHPASVAIAYRMKGNERFYLITDAMRAKGMPEGEYDLGG
QKVTVQSQQARLANGALAGSILKMNHGLRNLISFTGDTLDHLWRVTSLNQ
AIALGIDDRKGSIKVNKDADLVILDDDMNVKSTIKQGKVHTFS
>SAUSA300_1672 nagE, phosphotransferase system, N-acetylglucosamine-specific IIBC component
MYKFFQNLGRSLMLPVAILPAAAIIAGIGNTLNALHATPKIAMFFTTVGT
TILEQLGILFAIGVAIGMAKKNDGVVALAATLGYFLVTVVLSPMKLAPLL
GMKASEINSAFEKMNNGNVFVGIVIGLIAAYAYNKFSETELPLALSFFSG
KRLVPIMTAFYCTFLVVILLFLWPLLYSWIVKFGESIVGLGSFGAFIYGV
ANRLLIPTGLHHALNSVFWFDTIGINDIGKFQSGKDAIKGITGRYQAGFF
PIMMFGIPAAALAMYHTAKTTQKKQVYGWFLASSVAAFFVGVTEPIEFAF
MFVAPILYVVHALLTGLSLFIAATFHWTAGFSFSAGLIDYVLSLINPVSN
HPLMLLVQGVVFFILYYVIFRVVIQVFNLNTIGRGENELVDPTVVKDNIA
PGENDIKQSKYHQHAIQILEGLGGQENIVNLTNCATRLRLELKDTSIIDK
QKIKNAGAVGVTVNGKHSTQVIVGTHVQQVADEIEKHL
>SAUSA300_0680 norA, multi drug resistance protein
MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALS
QMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVI
GGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFM
AEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKIN
WKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIF
GALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANDYWSIMLISF
VVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGAL
FDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM
>SAUSA300_1645 pfkA, 6-phosphofructokinase
MNAAVRAVVRTAIYNEIEVYGVYHGYQGLLNDDIHKLELGSVGDTIQRGG
TFLYSARCPEFKEQEVRKVAIENLRKRGIEGLVVIGGDGSYRGAQRISEE
CKEIQTIGIPGTIDNDINGTDFTIGFDTALNTIIGLVDKIRDTASSHART
FIIEAMGRDCGDLALWAGLSVGAETIVVPEVKTDIKEIADKIEQGIKRGK
KHSIVLVAEGCMTAQDCQKELSQYINVDNRVSVLGHVQRGGSPTGADRVL
ASRLGGYAVDLLMQGETAKGVGIKNNKIVATSFDEIFDGKDHKFDYSLYE
LANKLSI
>SAUSA300_0310 pfoR, perfringolysin O regulator protein
MDLLIGTLFLFLVLVIFTLFTYKAPNGMRAMGALANAAIATFLVEAFNKY
VGGEVFGIKFLEELGDAAGGLGGVAAAGLTALAIGVSPVYALVIAAACGG
MDLLPGFFAGYMIGYVMKYTEKYVPDGVDLIGSIVILAPLARLIAVLLTP
VVNSTLIRIGDIIQSSTNTNPIIMGIILGGIITVVGTAPLSSMALTALLG
LTGVPMAIGAMAAFSSAFMNGTLFHRLKLGDRKSTIAVSIEPLSQADIVS
ANPIPIYITNFFGGAIAGLIIAMSGLINDATGTATPIAGFLVMFGFNHPT
TIVIYGVVMAIVGALAGYLGSIVFKKYPIVTKQDMINRGAVDA
>SAUSA300_0865 pgi, glucose-6-phosphate isomerase
MTHIQLDFSKTLEFFGEHELKQQQEIVKSIHKTIHEGTGAGSDFLGWVDL
PVDYDKEEFSRIVEASKRIKENSDVLVVIGIGGSYLGARAAIEMLTSSFR
NSNEYPEIVFVGNHLSSTYTKELVDYLADKDFSVNVISKSGTTTEPAVAF
RLFKQLVEERYGKEEAQKRIFATTDKEKGALKQLATNEGYETFIVPDDVG
GRYSVLTAVGLLPIATAGINIEAMMIGAAKAREELSSDKLEENIAYQYAT
IRNILYAKGYTTEMLINYEPSMQYFNEWWKQLFGESEGKDFKGIYPSSAN
YTTDLHSLGQYVQEGRRFLFETVVKVNHPKYDITIEKDSDDLDGLNYLAG
KTIDEVNTKAFEGTLLAHTDGGVPNMVVNIPQLDEETFGYVVYFFELACA
MSGYQLGVNPFNQPGVEAYKQNMFALLGKPGFEDLKKELEERL
>SAUSA300_0757 pgk, phosphoglycerate kinase
MAKKIVSDLDLKGKTVLVRADFNVPLKDGEITNDNRIVQALPTIQYIIEQ
GGKIVLFSHLGKVKEESDKAKLTLRPVAEDLSKKLDKEVVFVPETRGEKL
EAAIKDLKEGDVLLVENTRYEDLDGKKESKNDPELGKYWASLGDVFVNDA
FGTAHREHASNVGISTHLETAAGFLMDKEIKFIGGVVNDPHKPVVAILGG
AKVSDKINVIKNLVNIADKIIIGGGMAYTFLKAQGKEIGISLLEEDKIDF
AKDLLEKHGDKIVLPVDTKVAKEFSNDAKITVVPSDSIPADQEGMDIGPN
TVKLFADELEGAHTVVWNGPMGVFEFSNFAQGTIGVCKAIANLKDAITII
GGGDSAAAAISLGFENDFTHISTGGGASLEYLEGKELPGIKAINNK
>SAUSA300_0191 ptsG, PTS system, glucose-specific IIBC component domain protein
MRKKLFGQLQRIGKALMLPVAILPAAGLLLAIGTAMQGESLQHYLPFIQN
GGVQTVAKLMTGAGGIIFDNLPMIFALGVAIGLAGGDGVAAIAAFVGYII
MNKTMGDFLQVTPKNIGDPASGYASILGIPTLQTGVFGGIIIGALAAWCY
NKFYNINLPSYLGFFAGKRFVPIMMATTSFILAFPMALIWPTIQSGLNAF
STGLLDSNTGVAVFLFGFIKRLLIPFGLHHIFHAPFWFEFGSWKNAAGEI
IHGDQRIFIEQIREGAHLTAGKFMQGEFPVMMFGLPAAALAIYHTAKPEN
KKVVAGLMGSAALTSFLTGITEPLEFSFLFVAPLLFFIHAVLDGLSFLTL
YLLDLHLGYTFSGGFIDYFLLGILPNKTQWWLVIPVGLVYAVIYYFVFRF
LIVKLKYKTPGREDKQSQAATASATELPYAVLEAMGGKANIKHLDACITR
LRVEVNDKSKVDVPGLKDLGASGVLEVGNNMQAIFGPKSDQIKHEMQQIM
NGQVVENPTTMEDDKDETVVVAEDKSATSELSHIVHAPLTGEVTPLSEVP
DQVFSEKMMGDGIAIKPSQGEVRAPFNGKVQMIFPTKHAIGLVSDSGLEL
LIHIGLDTVKLNGEGFTLHVEEGQEVKQGDLLINFDLDYIRNHAKSDITP
IIVTQGNITNLDFKQGEHGNISFGDQLFEAK
>SAUSA300_2476 ptsG, phosphotransferase system, glucose-specific IIABC component
MFKKLFGQLQRIGKALMLPVAILPAAGILLAFGNAMHNEQLVEIAPWLKN
DIIVMISSVMEAAGQVVFDNLPLLFAVGTALGLAGGDGVAALAALVGYLI
MNATMGKVLHITIDDIFSYAKGAKELSQAAKEPAHALVLGIPTLQTGVFG
GIIMGALAAWCYNKFYNITLPPFLGFFAGKRFVPIVTSVVAIATGVLLSF
AWPPIQDGLNSLSNFLLNKNLTLTTFIFGIIERSLIPFGLHHIFYSPFWF
EFGSYTNHAGELVRGDQRIWMAQLKDGVPFTAGAFTTGKYPFMMFGLPAA
AFAIYKNARPERKKVVGGLMLSAGLTAFLTGITEPLEFSFLFVAPVLYGI
HVLLAGTSFLVMHLLGVKIGMTFSGGFIDYILYGLLNWDRSHALLVIPVG
IVYAIVYYFLFDFAIRKFKLKTPGREDEETEIRNSSVAKLPFDVLDAMGG
KENIKHLDACITRLRVEVVDKSKVDVAGIKALGASGVLEVGNNMQAIFGP
KSDQIKHDMAKIMSGEITKPSETTVTEEMSDEPVHVEALGTTDIYAPGIG
QIIPLSEVPDQVFAGKMMGDGVGFIPEKGEIVAPFDGTVKTIFPTKHAIG
LESESGVEVLIHIGIDTVKLNGEGFESLINVDEKVTQGQPLMKVNLAYLK
AHAPSIVTPMIITNLENKELVIEDVQDADPGKLIMTVK
>SAUSA300_0983 ptsH, phosphocarrier protein HPr
MEQNSYVIIDETGIHARPATMLVQTASKFDSDIQLEYNGKKVNLKSIMGV
MSLGVGKDAEITIYADGSDESDAIQAISDVLSKEGLTK
>SAUSA300_0984 ptsI, phosphoenolpyruvate-protein phosphotransferase
MSKLIKGIAASDGVAIAKAYLLVEPDLTFDKNEKVTDVEGEVAKFNSAIE
ASKVELTKIRNNAEVQLGADKAAIFDAHLLVLDDPELIQPIQDKIKNENA
NAATALTDVTTQFVTIFESMDNEYMKERAADIRDVSKRVLSHILGVELPN
PSMIDESVVIVGNDLTPSDTAQLNKEFVQGFATNIGGRTSHSAIMSRSLE
IPAIVGTKSITQEVKQGDMIIVDGLNGDVIVNPTEDELIAYQDKRERYFA
DKKELQKLRDADTVTVDGVHAELAANIGTPNDLPGVIENGAQGIGLYRTE
FLYMGRDQMPTEEEQFEAYKEVLEAMGGKRVVVRTLDIGGDKELSYLNLP
EEMNPFLGYRAIRLCLAQQDIFRPQLRALLRASVYGKLNIMFPMVATINE
FREAKAILLEEKENLKNEGHDISDDIELGIMVEIPATAALADVFAKEVDF
FSIGTNDLIQYTLAADRMSERVSYLYQPYNPSILRLVKQVIEASHKEGKW
TGMCGEMAGDETAIPLLLGLGLDEFSMSATSILKARRQINGLSKNEMTEL
ANRAVDCATQEEVIELVNNYVK
>SAUSA300_1644 pyk, pyruvate kinase
MRKTKIVCTIGPASESEEMIEKLINAGMNVARLNFSHGSHEEHKGRIDTI
RKVAKRLDKIVAILLDTKGPEIRTHNMKDGIIELERGNEVIVSMNEVEGT
PEKFSVTYENLINDVQVGSYILLDDGLIELQVKDIDHAKKEVKCDILNSG
ELKNKKGVNLPGVRVSLPGITEKDAEDIRFGIKENVDFIAASFVRRPSDV
LEIREILEEQKANISVFPKIENQEGIDNIAEILEVSDGLMVARGDMGVEI
PPEKVPMVQKDLIRQCNKLGKPVITATQMLDSMQRNPRATRAEASDVANA
IYDGTDAVMLSGETAAGLYPEEAVKTMRNIAVSAEAAQDYKKLLSDRTKL
VETSLVNAIGISVAHTALNLNVKAIVAATESGSTARTISKYRPHSDIIAV
TPSEETARQCSIVWGVQPVVKKGRKSTDALLNNAVATAVETGRVSNGDLI
IITAGVPTGETGTTNMMKIHLVGDEIANGQGIGRGSVVGTTLVAETVKDL
EGKDLSDKVIVTNSIDETFVPYVEKALGLITEENGITSPSAIVGLEKGIP
TVVGVEKAVKNISNNMLVTIDAAQGKIFEGYANVL
>SAUSA300_0263 rbsD, ribose permease
MKKSAILNEHISKAIATIGHFDLLTINDAGMPIPNDHRRIDLAVTKNLPR
FIDVLATVLEEMEIQKIYLAEEIKEHNPTQLQQIKQLISSEIEIIFIPHE
EMKSNLAHPLNKGNIRTGETTPYSNIALESNVTF
>SAUSA300_0262 rbsK, ribokinase
MTNKVVILGSTNVDQFLTVERYAQPGETLHVEEAQKAFGGGKGANQAIAT
ARMQADTTFITKIGTDGVADFILEDFKVAHIDTSYIIKTAEAKTGQAFIT
VNAEGQNTIYVYGGANMTMTPEDVINAKDAIINADFVVAQLEVPIPAIIS
AFEIAKAHGVTTVLNPAPAKALPNELLSLIDIIVPNETEAELLSGIKVTN
EQSMKDNANYFLSIGIKTVLITLGKQGTYFATKNQSQHIEAYKVNAIDTT
AAGDTFIGAFVSRLNKSQDNLADAIDFGNKASSLTVQKHGAQASIPLLEE
VNQV
>SAUSA300_1115 rpe, ribulose-phosphate 3-epimerase
MTKLYPSLLSVDFLDLQHELKRLEEAGVDGVHFDVMDGQFVPNISIGLPI
LDAVRKGTTLPIDVHLMIENPEKYIASFAEHGADMISIHVESTPHIHRAI
QMIKHLDKKAGVVINPGTPISQIEPILDIVDYVLVMTVNPGFGGQSFIDQ
CVEKIAGLNAIKMERQLNFDIEVDGGVNTDTAKVCVENGATMLVTGSFFF
KQEDYKKVTQALKG
>SAUSA300_2283 rpiA, ribose 5-phosphate isomerase A
MKDVKALKLMTLNDVLSQINGDMTLGIGTGSTMELLLPQMAQLIKERGYN
ITGVCTSNKIAFLAKELGIKICEINDVDHIDLAIDGADEVDPSLNIIKGG
GGALFREKVIDEMASRFVVVVDETKIVQYLGETFKLPVEVDKFNWYHILR
KIESYADIKVERRVNEDVAFITDNGNYILDCKLPKGIDPYKFHEYLIHLT
GVFETGYFLDMADQVIVGTQEGVKILEK
>SAUSA300_1994 scrB, sucrose-6-phosphate hydrolase
MTEWTREERYQRIEDVDTEYFKTLKQQVDQSKFRQQFHIQPETGLLNDPN
GLIFYKGKYYVSHQWFPLGAVHGLKYWYNYTSDDLINFKAEGPILNPDTK
YDSHGVYSGSAFEYNGHLYYMYTGNHRDNHWQRHASQMIARLKEDGSVEK
FPKPVISQQPEGYTSHFRDPKVFKYDEKYYAIIGAQNNDQQGRLLLYNTE
DIINWHYLGEINTELDDFGYMWECPDYFNVDNQDVILICPQGIEPKGDQF
KNIYQSGYILGKFDIEKLTYEHENFVELDNGFDFYAPQTFLDEKGRRVLI
GWMGLPEIEYPTDNEGWAHCLTIPRVLNVENGQLKQRPYPALEKLRHNKE
TALGYANKFTRKLHPYEGKQYELIIDILDNDATEVYFELRTSKTSSTLIA
YNKRENKITLDRSDSGLLPTNVEGTTRSTILDTPLKQLQIFVDTSSIEIF
CNDGERVLTSRIFPTEDALGIKTSTESGQVYLQFTKYDLKDEHK
>SAUSA300_0625 tagG, teichoic acid ABC transporter protein
MSAIGTVFKEHVKNFYLIQRLAQFQVKIINHSNYLGVAWELINPVMQIMV
YWMVFGLGIRSNAPIHGVPFVYWLLVGISMWFFINQGILEGTKAITQKFN
QVSKMNFPLSIIPTYIVTSRFYGHLGLLLLVIIACMFTGIYPSIHIIQLL
IYVPFCFFLTASVTLLTSTLGVLVRDTQMLMQAILRILFYFSPILWLPKN
HGISGLIHEMMKYNPVYFIAESYRAAILYHEWYFMDHWKLMLYNFGIVAI
FFAIGAYLHMKYRDQFADFL
>SAUSA300_0624 tagH, teichoic acid translocation ATP-binding protein
MNVSVNIKNVTKEYRIYRTNKERMKDALIPKHKNKTFFALDDISLKAYEG
DVIGLVGINGSGKSTLSNIIGGSLSPTVGKVDRNGEVSVIAISAGLSGQL
TGIENIEFKMLCMGFKRKEIKAMTPKIIEFSELGEFIYQPVKKYSSGMRA
KLGFSINITVNPDILVIDEALSVGDQTFAQKCLDKIYEFKEQNKTIFFVS
HNLGQVRQFCTKIAWIEGGKLKDYGELDDVLPKYEAFLNDFKKKSKAEQK
EFRNKLDESRFVIK
>SAUSA300_2301 tcaB, teicoplanin resistance associated membrane protein TcaB protein
MNDLTHFNKRSPIFIIILGSLTAIGALSIDMFLPGLPDIRHDFQTTTSNA
QLTLSMFMIGLAFGNLFAGPISDSTGRRKPLIIAMIIFTLASLGIVFVHN
IWLMVALRFLQGVTGGAAAVISRAIASDMYSGNELTKFMALLMLVNGIAP
VVAPTIGGIILNYSVWRMVFVILTIFGFVMVIGSLLKVPESLTVTNRESS
SGLKTMFKNFKILLKTPRFVLPMLIQGMTFVILFTYISASPFIIQKIYGM
TAIQFSWMFAGIGITLIISSQLTGYLVDFIDSQKLMRGMTMIQIIGVILV
TIVLLNHWNFWILAIGFIILIAPVTGVATLGFTIAMDESSSGRGSSSSLL
GLVQFLFGGVASPLVGVKGEDNPIPYIIIIIATAVILIILQIYNMKVFKT
NR
>SAUSA300_1239 tkt, transketolase
MAYTLWTRHLNFNPQSKDYFNRDRFVLSAGHGSALLYSLLHVSGSLELEE
LKQFRQWGSKTPGHPEYRHTDGVEVTTGPLGQGFAMSVGLALAEDHLAGK
FNKEGYNVVDHYTYVLASDGDLMEGISHEAASFAGHNKLSKLVVLYDSND
ISLDGELNKAFSENTKARFEAYGWNYLLVKDGNDLEEIDKAITTAKSQEG
PTIIEVKTTIGFGSPNKAGTNGVHGAPLGEVERKLTFENYGLDPEKRFNV
SEEVYEIFQNTMLKRANEDESQWNSLLEKYAETYPELAEEFKLAISGKLP
KNYKDELPRFELGHNGASRADSGTVIQAISKTVPSFFGGSADLAGSNKSN
VNDATDYSSETPEGKNVWFGVREFAMGAAVNGMAAHGGLHPYGATFFVFS
DYLKPALRLSSIMGLNATFIFTHDSIAVGEDGPTHEPIEQLAGLRAIPNM
NVIRPADGNETRVAWEVALESESTPTSLVLTRQNLPVLDVPEDVVEEGVR
KGAYTVYGSEETPEFLLLASGSEVSLAVEAAKDLEKQGKSVRVVSMPNWN
AFEQQSEEYKESVIPSSVTKRVAIEMASPLGWHKYVGTAGKVIAIDGFGA
SAPGDLVVEKYGFTKENILNQVMSL
>SAUSA300_0758 tpiA, triosephosphate isomerase
MRTPIIAGNWKMNKTVQEAKDFVNALPTLPDSKEVESVICAPAIQLDALT
TAVKEGKAQGLEIGAQNTYFEDNGAFTGETSPVALADLGVKYVVIGHSER
RELFHETDEEINKKAHAIFKHGMTPIICVGETDEERESGKANDVVGEQVK
KAVAGLSEDQLKSVVIAYEPIWAIGTGKSSTSEDANEMCAFVRQTIADLS
SKEVSEATRIQYGGSVKPNNIKEYMAQTDIDGALVGGASLKVEDFVQLLE
GAK
>SAUSA300_0449 treC, alpha,alpha-phosphotrehalase
MSKEIDWRKSVVYQIYPKSFNDTTGNGIGDINGIIEKLDYIKLLGVDYIW
LTPVYESPMNDNGYDISNYLEINEDFGTMDDFEKLIKVAHQKDLKVMLDI
VINHTSTEHEWFKEARKSKDNPYRDYYFFRSSEDGPPTNWYSKFGGNAWK
YDSETDEYYLHLFDVSQADLNWDNPEVRQSLYRIVNHWIDFGVDGFRFDV
INLISKGEFKDSDKIGKEFYTDGPRVHEFLHELNRQTFGNTDMMTIGEMS
STTIENCIKYTQPERQELNSVFNFHHLKVDYVDGEKWTNAKLDFHKLKEI
LMQWQRGIYDGGGWNAIFWCNHDQPRVVSRFGDDTSEEMRIQSAKMLAIA
LHMLQGTPYIYQGEEIGMTDPHFTSIAQYRDVESINAYHQLLSEGHAEAD
VLAILGQKSRDNSRTPMQWSDDVNAGFTAGKPWIDISENYHQVNVRQALQ
NKESIFYTYQKLIQLRHTHDIITYGDIVPRFMDHDHLFVYERHYKNQQWL
VIANFSASAVDLPEGLAREGCVVIQTGTVENNTISGFGAIVIETNA
>SAUSA300_0448 treP, PTS system, trehalose-specific IIBC component
MAVKREDVKAIVTAIGGKENLEAATHCVTRLRLVLKDESKVDKDALSNNA
LVKGQFKADHQYQIVIGPGTVDEVYKQFIDETGAQEASKDEAKQAAAQKG
NPVQRLIKLLGDIFIPILPAIVTAGLLMGINNLLTMKGLFGPKALIEMYP
QIADISNIINVIASTAFIFLPALIGWSSMRVFGGSPILGIVLGLILMHPQ
LVSQYDLAKGNIPTWNLFGLEIKQLNYQGQVLPVLIAAYVLAKIEKGLNK
VVHDSIKMLVVGPVALLVTGFLAFIIIGPVALLIGTGITSGVTFIFQHAG
WLGGAIYGLLYAPLVITGLHHMFLAVDFQLMGSSLGGTYLWPIVAISNIC
QGSAAFGAWFVYKRRKMVKEEGLALTSCISGMLGVTEPAMFGVNLPLKYP
FIAAISTSCVLGAIVGMNNVLGKVGVGGVPAFISIQKEFWPVYLIVTAIA
IVVPCILTIVMSHFSKQKAKEIVED
>SAUSA300_0216 uhpT, hexose phosphate transport protein
MNFFDIHKIPNKGIPLSVQRKLWLRNFMQAFFVVFFVYMAMYLIRNNFKA
AQPFLKEEIGLSTLELGYIGLAFSITYGLGKTLLGYFVDGRNTKRIISFL
LILSAITVLIMGFVLSYFGSVMGLLIVLWGLNGVFQSVGGPASYSTISRW
APRTKRGRYLGFWNTSHNIGGAIAGGVALWGANVFFHGNVIGMFIFPSVI
ALLIGIATLFIGKDDPEELGWNRAEEIWEEPVDKENIDSQGMTKWEIFKK
YILGNPVIWILCVSNVFVYIVRIGIDNWAPLYVSEHLHFSKGDAVNTIFY
FEIGALVASLLWGYVSDLLKGRRAIVAIGCMFMITFVVLFYTNATSVMMV
NISLFALGALIFGPQLLIGVSLTGFVPKNAISVANGMTGSFAYLFGDSMA
KVGLAAIADPTRNGLNIFGYTLSGWTDVFIVFYVALFLGMILLGIVAFYE
EKKIRSLKI
>SAUSA300_1454 zwf, glucose-6-phosphate 1-dehydrogenase
MSTKNKHIPCLITIFGATGDLSHRKLFPSIFHLYQQDNLDEHIAIIGIGR
RDITNDDFRNQVKSSIQKHVKDTNKIDAFMEHVFYHRHDVSNEESYQELL
DFSNELDSQFELKGNRLFYLAMAPQFFGVISDYLKSSGLTDTKGFKRLVI
EKPFGSDLKSAEALNNQIRKSFKEEEIYRIDHYLGKDMVQNIEVLRFANA
MFEPLWNNKYISNIQVTSSEILGVEDRGGYYESSGALKDMVQNHMLQMVA
LLAMEAPISLNSEDIRAEKVKVLKSLRHFQSEDVKKNFVRGQYGEGYIDG
KQVKAYRDEDRVADDSNTPTFVSGKLTIDNFRWAGVPFYIRTGKRMKSKT
IQVVVEFKEVPMNLYYETDKLLDSNLLVINIQPNEGVSLHLNAKKNTQGI
ETEPVQLSYSMSAQDKMNTVDAYENLLFDCLKGDATNFTHWEELKSTWKF
VDAIQDEWNMVDPEFPNYESGTNGPLESDLLLARDGNHWWDDIQ